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ABSTRACT 
Assessment of the Canine Intestinal Microflora using  
Molecular Methods and Serum Markers. (December 2005) 
Jan S. Suchodolski, med. vet.; Dr. med. vet., University of Veterinary Medicine, Vienna, 
Austria 
 Co-Chairs of Advisory Committee:  Dr. Gerald G. Wagner 
 Dr. David A. Williams 
 
 
 
Previous studies examining the canine intestinal microflora have focused on 
cultivation of bacteria from intestinal content. Recently, it has been recognized that the 
majority of bacteria cannot be identified using standard culture techniques. The aim of 
this study was to describe the composition and dynamics of the canine intestinal 
microflora using molecular methods based on identification of the 16S ribosomal DNA 
(16S rDNA) and to evaluate the clinical use of a 13C-glycocholic acid blood test (13C-
GCBT) as a serum marker for small intestinal bacterial biomass. Intestinal content was 
obtained from healthy dogs and the microflora was characterized in different 
compartments of each dog by denaturing gradient gel electrophoresis (DGGE) and 
comparative 16S rDNA analysis. A 13C-glycocholic acid blood test (13C-GCBT) was 
developed as a marker for small intestinal bacterial biomass and the influence of tylosin 
administration on the 13C-GCBT, serum concentrations of cobalamin, folate, and 
unconjugated cholic acid (SUCA) was evaluated. There was marked variation in DGGE 
profiles between individual dogs and also between different intestinal compartments 
within dogs. DGGE profiles from duodenal juice samples collected endoscopically at 
different time-points varied within individuals, possibly due to variations over time or a 
slight variation in sampling location. Direct sequencing revealed 106 individual 16S 
rDNA sequences. Forty-two sequences showed less than 98% similarity to described 
sequences in public databases and may constitute previously uncharacterized bacterial 
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species. Serum folate concentrations, SUCA, and the cumulative percent dose/min of 13C 
administered as 13C-glycocholic acid (CUMPCD) increased significantly following 
tylosin administration (p<0.01). The results indicate that dogs have a complex intestinal 
microflora with marked differences between individual dogs. Different intestinal 
compartments appear to host a unique microflora and the assessment of a fecal sample 
does not yield accurate information about the composition of the microflora in proximal 
compartments of the gut. The intestine harbors many previously uncharacterized 
bacterial species. The clinical significance of these uncharacterized intestinal bacterial 
species needs to be further investigated in dogs with gastrointestinal disease. Increased 
serum folate, SUCA, and CUMPCD in the 13C-GCBT suggest that, in the dogs described 
here, tylosin administration increased the biomass of organisms carrying out these 
metabolic functions.  
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CHAPTER I 
INTRODUCTION 
THE CANINE INTESTINAL MICROFLORA 
The canine intestinal microflora has been mainly evaluated by direct culture 
techniques. It has been reported that the normal canine duodenal microflora harbors a 
total bacterial count below 105 colony forming units per ml of duodenal juice (cfu/ml) 
(77). Higher duodenal bacterial counts were considered to contribute to intestinal disease 
and lead to a clinical syndrome termed small intestinal bacterial overgrowth (SIBO) 
(77). Significantly higher counts, however, have subsequently been documented in dogs 
with no signs of intestinal disease (41), leading to controversy over the true quantitative 
composition of the healthy canine duodenal microflora. The jejunal microflora is 
quantitatively similar to the duodenal microflora (6) whereas the ileal microflora 
increases in bacterial counts to approximately 107 cfu/ml (6, 10, 17). The total bacterial 
count in the colon ranges between approximately 109 and 1011 cfu/ml (6, 17). Benno et 
al. described the canine intestinal microflora in different compartments of the 
gastrointestinal tract and in two different age groups using bacterial culture techniques 
(6). In dogs, less than 12 months of age the mean (±SD) aerobic bacterial count in the 
duodenum was log10 5.2 (±1.9) cfu/ml, and the total anaerobic count was log10 4.8 (±1.4) 
cfu/ml. These bacterial counts in the duodenum were higher than cut-off value 
previously recommended for SIBO. Bacteroides, Clostridium, Lactobacillus, 
Bifidobacterium, and Enterobacteriaceae spp. were the predominant bacterial groups 
cultivable from the canine intestine. Also, in one study the small intestine of older dogs 
(more than 11 years old) showed no qualitative or quantitative differences in bacteria 
compared to a group of younger dogs.  
__________________                                                             
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However, there was a qualitative change in the bacterial microflora of the large intestine 
between these two groups. Older dogs had an increase in Bacteroides, Clostridium, and 
Streptococcus spp. with a decrease in Bifidobacterium, and Lactobacillus spp.  
Another study evaluated postnatal changes of the small intestinal microflora in 
puppies (10). Bacterial counts in the small intestine were highest in 1 day old puppies 
and decreased significantly thereafter but remaining stable after day 42 with aerobic 
bacterial count of log10 7 cfu/g and anaerobic count of approximately log10 8 cfu/g, 
respectively. 
Differences exist in bacterial counts between the intestinal lumen and the duodenal 
mucosa as fewer of the bacteria adherent to the mucosa have been isolated (18). 
 
MECHANISMS REGULATING THE INTESTINAL MICROFLORA IN 
HEALTHY DOGS  
Bacteria are constantly ingested with food. There are several physiological 
mechanisms that regulate bacterial colonization in the intestine including secretion of 
gastric acid and antibacterial factors (i.e., pancreatic and biliary secretions) in the small 
intestine, and most importantly, intestinal motility. Most ingested bacteria are inactivated 
by gastric acid. Humans with atrophic gastritis or who undergo acid suppressant therapy 
(e.g., omeprazole treatment) show an increase in bacterial counts in the small intestine 
(11, 22). In one case report a single dog was evaluated for chronic gastrointestinal 
disease, causing chronic diarrhea and weight loss (95). Based on quantitative and 
qualitative bacterial culture this dog was diagnosed with small intestinal bacterial 
overgrowth. The pH of fasted gastric juice was 7.0 (normal < 3.0). The authors 
concluded that achlorhydria was responsible for development of SIBO in this dog. In 
another study high gastric pH, despite stimulation with histamine, was observed in a dog 
with suspected bacterial overgrowth due to intestinal malabsorption (34).  
The pancreatic juice contains antimicrobial substances that suppress excessive 
bacterial growth in the proximal small intestine (108). Dogs with spontaneous exocrine 
pancreatic insufficiency (EPI) appear to have a higher incidence of duodenal bacterial 
overgrowth. In one study 8 out of 11 dogs with EPI showed elevated bacterial counts 
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based on duodenal culture results (109). In another study, six dogs with EPI that 
received no treatment of any kind had > 106 colony forming units per ml duodenal juice 
(cfu/ml). Similar to this untreated group, six additional dogs that received only 
pancreatic enzyme supplementation also had elevated bacterial counts. Dogs that 
received both, pancreatic enzyme supplementation and antibiotic therapy, had 
significantly lower duodenal bacterial counts when compared to the first two groups. In 
another study 6 dogs underwent pancreatic duct ligation as a model for experimentally 
induced EPI (91). Total numbers of aerobic and anaerobic bacteria present in the 
duodenum increased significantly after pancreatic duct ligation. There was also a 
qualitative change in the microflora, with an increase in Lactobacillus spp. and 
Streptococcus spp. in 3 of 6 dogs, and an increase in Bacteroides spp. and Clostridium 
spp. in the other three dogs. Treatment with pancreatic enzyme supplementation (bovine 
pancreatic extract) led to a reduction in bacterial numbers to pre-surgical levels (91).  
The ileocolic valve is believed to serve as a natural barrier between the small and 
large intestine in dogs (31). This barrier, together with intestinal motility, is believed to 
prevent retrograde translocation of bacteria from the large into the small intestine. 
Dysfunction of the ileocolic valve has been suggested as one possible cause of bacterial 
dysregulation, such as small intestinal bacterial overgrowth (31, 45). Normal intestinal 
motility is believed to be the most important factor to maintain the physiologic balance 
of the intestinal microflora. Blind and stagnant loops are a common site of bacterial 
overgrowth in humans and motility changes after surgery predispose to bacterial 
overgrowth in humans (29). In a case report a dog diagnosed with duodenal bacterial 
overgrowth was shown to have two blind intestinal loops on necropsy (110).     
INTESTINAL MICROFLORA AND HOST HEALTH 
The resident intestinal microflora offers nutritional benefit to the host by 
production of short chain fatty acids (e.g., butyrate, propionate, and acetate), which 
stimulate mucosal growth and epithelial cell proliferation. Lactate produced by microbial 
fermentation also serves as an energy source for the host. In addition, the normal 
intestinal microflora plays a major role in protection of the host from invasion by 
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harmful bacteria through competitive exclusion of potentially pathogenic organisms. The 
implicated defense mechanisms include competition for oxygen and nutrient substrates, 
competition for mucosal adhesion sites, creation of a physiologically restrictive 
environment for non-resident bacterial species (e.g., production of metabolic substances 
that are toxic to other bacteria, changes in pH and redox potential, hydrogen sulfide 
production), and secretion of antimicrobial substances (e.g., bacteriocins) (43). In animal 
models Lactobacillus plantarum significantly reduced bacterial translocation into 
mesenteric lymphnodes and the pancreas in rats with experimentally induced pancreatitis 
(53). Lactobacillus johnsonii, a bacterium that is used as a probiotic and is native to the 
small intestine is able to compete with enteropathogens for the same carbohydrate 
receptors in vitro, thus potentially preventing adhesion of pathogenic bacteria in the gut 
(65).  
Anecdotal evidence existed for many years that feeding of yoghurt, containing 
lactic acid bacteria, exhibits a beneficial effect on the host. However, only recently, well 
designed double blinded prospective studies have been published that have evaluated the 
contributions of probiotics and prebiotics to the prevention and treatment of intestinal 
disease by modulating the intestinal microflora in order to increase the number of 
“protective” bacteria (79). Probiotics are defined as viable microorganisms, that when 
ingested, promote prevention and treatment of specific pathological conditions (79). 
Probiotics include Lactobacillus spp., Bifidobacterium spp., Streptococcus spp., 
Enterococcus faecium, non-pathogenic Escherichia coli strains, and Saccharomyces 
boulardii. Prebiotics are non digestible food ingredients that beneficially affect the host 
by stimulating the growth and/or activity of beneficial bacteria in the colon. Most 
commonly used prebiotics are inulin, fructooligosaccharides (FOS), and oligofructose.  
In order for a probiotic to be effective it must to have several properties; it must be: 1) 
acid resistant in order to survive passage through the stomach, 2) resistant to bile acids, 
and 3) able to colonize the intestine for an extended period of time. Several recent 
studies have evaluated these properties for various probiotic strains in vitro and in vivo 
in order to select potential probiotic strains for future clinical use. Results of these 
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studies indicate that most probiotics can be recovered in fecal samples, indicating that 
they are viable in the intestinal tract, but most probiotics are quickly eliminated when 
therapy is discontinued (79). Thus, most present probiotics do not appear to colonize the 
intestinal tract and, in order to exhibit a beneficial effect in the host, prolonged 
administration of high doses (usually >1010 cfu/g) is necessary. Only few prospective 
double-blinded placebo controlled studies have been published that evaluate the effect of 
probiotics in humans with intestinal disease. Probiotic strains, including Lactobacillus 
spp., Enterococcus faecium, and Saccharomyces boulardii, have been demonstrated to 
be useful in prevention of antibiotic-induced diarrhea and traveler’s diarrhea (7). 
However, it is important to note that probiotic therapy, while significantly reducing the 
incidence of diarrhea, did not prevent disease in all tested subjects. Thus probiotic 
therapeutics containing only selected microorganisms might be useful only for a 
subpopulation of patients and it is possible that different patients require different strains 
of probiotics in order to have a protective effect.  
THE INTESTINAL MICROFLORA IN DISEASE 
In a study published in 1983 the duodenal microflora was compared between 
German Shepherd dogs with chronic gastrointestinal disease and healthy Beagle dogs 
(5). In this study bacterial counts in dogs with diarrhea were significantly higher than in 
healthy dogs. The authors concluded that intestinal disease was caused by bacterial 
overgrowth in the small intestine and proposed that total bacterial counts higher than 105 
colony forming units per ml of duodenal fluid (cfu/ml) or an anaerobic count higher than 
104 cfu/ml was diagnostic for small intestinal bacterial overgrowth (SIBO). These cut-
off values are similar to those established for diagnosis of SIBO in humans (4).  
Proposed effects of an abnormal bacterial flora include damage of carrier 
proteins with subsequent decrease in absorption of amino acids and monosaccharides, 
increased deconjugation of bile acids resulting in disturbed fat malabsorption, secretion 
of toxins that are toxic to enterocytes, hydroxylation of fatty acids contributing to 
diarrhea, and competition for nutrients und vitamins (e.g., cobalamin) (41).   
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Subsequent studies performed in dogs with intestinal disease used the above 
criteria for diagnosing SIBO in dogs (107). Significantly higher counts, however, have 
subsequently been documented in dogs with no signs of intestinal disease (41), leading 
to controversy over the true quantitative composition of the normal canine duodenal 
microflora. Recent studies performed in dogs with chronic enteropathies found no 
correlation between the number of bacterial counts in the duodenum and clinical signs 
(25). Some dogs with suspected SIBO had numbers that were substantially lower than 
105 cfu/ml. Since this condition usually responds to antibiotic treatment, some authors 
propose the term “antibiotic responsive diarrhea” rather than SIBO (25). However, it 
should be pointed out that both terms can not be used synonymously as some dogs 
diagnosed with SIBO based on findings traditionally associated with SIBO do not 
respond to antibiotic therapy and some dogs that respond to antibiotic therapy do not 
have findings typically associated with SIBO.    
Inflammatory bowel disease (IBD) is one of the most common chronic 
enteropathies in humans as well as dogs (39). It has been hypothesized that IBD is 
caused by a loss of tolerance to commensal bacteria or due to bacterial dysregulation 
(51). The commensal intestinal microflora may contribute or maintain intestinal 
inflammation in patients with IBD. A study in human patients with active inflammatory 
bowel disease has shown a reduced bacterial diversity in the colon compared to healthy 
controls as demonstrated by molecular fingerprinting (67). From 3 individuals bacteria 
were also identified by direct 16S rDNA sequence analysis. The majority of identified 
bacteria belonged to the normal anaerobic microflora of the human gut. However, 30% 
of obtained 16S rDNA sequences represented not yet characterized bacterial species and 
their role in the pathogenesis of human IBD needs to be further investigated.  A study 
evaluating bacterial diversity of colonic mucosal samples from patients with ulcerative 
colitis using quantitative dot blot hybridization have found an increase in 
Enterobacteriacae and a decrease in “protective” bacteria such as Lactobacillus and 
Bifidobacteria spp. (83).  
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CHARACTERIZATION OF THE INTESTINAL MICROFLORA 
Previous studies characterizing the intestinal bacterial flora in humans and 
various other species have focused on the identification and enumeration of bacterial 
species through direct cultivation of intestinal content (6, 17). Recently, limitations of 
bacterial culture have been recognized. Bacterial culture is technically complex and 
expensive. Anaerobic bacteria are potentially more prone to damage during sampling, 
shipping, and storage. Different laboratories use different protocols and not all selective 
media are completely selective. For example, a study characterizing the fecal microflora 
from a Labrador Retriever dog demonstrated that despite using Beerens agar, a medium 
designed for the isolation of Bifidobacterium spp., a mixture of various organism other 
than Bifidobacterium spp. were isolated (30). Today it is generally recognized that the 
majority of microbial species present in intestinal samples can not be cultured. This is 
believed to be due our lack of knowledge of microbial growth requirements. In contrast, 
studies using molecular methods have identified a greater number of bacterial species 
present in the intestine of various species (37, 70, 96). It is important to note that these 
initial studies have focused almost exclusively on the fecal microflora. Also, samples 
from only few individuals have been analyzed. Based on a 98% similarity criterion 
(which is commonly used in these types of studies), 82 operative taxonomical units 
(OTU) were described in a fecal sample of one healthy man (96). Only 24% of these 
OTUs belonged to previously characterized bacterial species. Based on phylogenetic 
analysis the majority of obtained OTUs belonged to the orders Bacteroidales and 
Clostridiales. Hayashi and coworkers evaluated the fecal microflora from 3 healthy 
individuals (33). They identified 130 unique OTUs, and only 25% of these had greater 
than 98% similarity to previously characterized bacterial species. In this study the 
majority of bacteria were Clostridium, Bacteroides, Bifidobacterium, and Streptococcus 
spp. Interestingly, in contrast to Hayashi et al., the study performed by Suau et al., failed 
to identify members of the Bifidobacterium group, believed to be well established 
members of the human colonic microflora (19). The authors contributed this finding to 
potential mismatches between the nucleotide sequences of commonly used universal 
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primers and nucleotide sequences specific for Bifidobacterium spp., indicating a 
potential shortcoming of direct 16S rDNA sequence analysis.  
In humans most studies evaluating the intestinal microflora have some 
limitations: due to the ease of collection only fecal samples have been analyzed in most 
studies and only a small number of subjects have been evaluated. Studies in pigs and 
chickens using molecular fingerprinting and direct 16S rDNA analysis have 
demonstrated that the intestinal microflora varies in different compartments of the 
intestinal tract (72, 102). Recent studies have evaluated the microflora, using direct 16S 
rDNA analysis and molecular fingerprinting, of both luminal samples and mucosal 
biopsies obtained from the ileum and colon of humans (97, 104, 114). These studies 
have demonstrated qualitative variations in the intestinal microflora between fecal 
samples and samples obtained from more proximal parts of the intestine. Also mucosa 
adherent populations were different from luminal bacteria (114). Fewer members of 
Bacteroides were found in the gut-adherent microflora when compared to that of the 
intestinal lumen (114). Recent studies have also demonstrated remarkable inter-
individual variation in human fecal samples (111). Also, it has been reported that 
monozygotic twins have a significantly higher similarity of fecal molecular 
fingerprinting patterns than unrelated individuals, suggesting the host’s genotype may 
have an influence on the intestinal microflora (111).  
MOLECULAR FINGERPRINTING TECHNIQUES 
Molecular fingerprinting techniques, e.g. denaturing gradient gel electrophoresis 
(DGGE) allow rapid assessment of the predominant bacterial species present in a 
sample. Molecular fingerprinting techniques are commonly used to assess genetic 
diversity in a complex microbial community (49, 90). Amplification of 16S rDNA with 
subsequent separation of amplicons by denaturing gradient gel electrophoresis (DGGE) 
has been used for evaluation of bacterial diversity in environmental samples (63). The 
principle of DGGE is based on the decreasing electrophoretic mobility of double-
stranded DNA as it is partially melted (64). Briefly, DNA is extracted from biological 
samples, and 16S rDNA amplified using universal primers that target conserved regions 
 9 
(located up- and downstream of variable regions) within the gene encoding 16S rRNA. 
This approach allows amplification of unknown bacterial species. The mixture of PCR 
products, all approximately of the same length, are subsequently separated on a 
polyacrylamide gel containing a linear gradient of DNA denaturants (63). Sequence 
differences in the double stranded DNA influence the melting behavior of PCR 
amplicons. Therefore, PCR amplicons with a differing sequence will stop migrating at 
different positions in the gel. This results in the separation of amplicons, and a pattern of 
separated bands that illustrates the bacterial diversity in a sample. The DGGE profile 
typically represents up to 99% of the total bacterial community present in a biological 
sample (63). While molecular fingerprinting does not allow for immediate 
discrimination between bacterial species, it does allow for simultaneous analysis of 
multiple samples and, thus, direct comparison of microbial communities from different 
samples (63). Molecular fingerprinting further allows the study of changes in individual 
microbial communities over time and in response to treatment. Also, molecular 
fingerprinting has been used to evaluate differences in bacterial diversity between 
healthy and diseased individuals. For example, a reduction in bacterial diversity has been 
found in the colonic microflora of humans with active inflammatory bowel disease, 
warranting similar bacterial diversity studies in dogs with intestinal disease (67). 
SERUM MARKERS FOR ASSESSMENT OF THE SMALL INTESTINAL 
MICROFLORA 
While molecular techniques allow for accurate identification and characterization 
of intestinal bacteria they are impractical for clinical application as sampling of intestinal 
content requires invasive procedures such as endoscopy or laparoscopy. Several indirect 
serum markers are commonly used for assessment of small intestinal bacterial biomass. 
These include serum concentrations of vitamins, cobalamin and folate, and measurement 
of serum unconjugated cholic acid (SUCA). 
Serum cobalamin and folate concentrations. Cobalamin (vitamin B12) and 
folate uptake from the small intestine can be affected by several factors and can 
therefore be utilized as an indirect marker of gastrointestinal disease. Small intestinal 
 10 
inflammation, exocrine pancreatic insufficiency (EPI), and small intestinal bacterial 
overgrowth (SIBO) all can lead to changes in serum cobalamin and/or folate 
concentrations (108). In addition, measurement of serum cobalamin and folate may yield 
information on the site and cause of intestinal disease. Cobalamin is a water-soluble 
vitamin and an important co-factor for a variety of biochemical reactions. Cobalamin is 
usually abundant in commercial canine and feline diets, making a dietary insufficiency 
unlikely. The mechanisms involved in cobalamin absorption are complex and depend on 
intact gastrointestinal function.  In the diet, cobalamin is tightly bound to dietary protein. 
After digestion of these dietary proteins in the stomach by pepsin and hydrochloric acid, 
cobalamin is released and immediately bound to R-protein, a protein secreted in saliva 
and gastric juice. Pancreatic enzymes (i.e., trypsin and chymotrypsin) digest R-protein, 
again releasing cobalamin. Intrinsic factor, produced in the stomach and pancreas binds 
to cobalamin and serves as a transporter to the distal small intestine (i.e., ileum) where 
the cobalamin/intrinsic factor complexes are absorbed by specific receptors located in 
the ileal mucosa. 
Folate is also a water soluble vitamin that, similarly to cobalamin, is abundant in 
commercial canine and feline diets, again making a nutritional deficiency unlikely. 
Dietary folate is usually present in the poorly absorbable polyglutamate form. Folate 
deconjugase, a brush border enzyme secreted in the jejunum, removes all but one 
glutamate residue from the molecule. Specific carriers for folate monoglutamate in the 
proximal small intestine will promote folate uptake.  
Assessment of serum cobalamin and folate concentrations is the most clinically 
useful aid in the diagnosis of SIBO although they have poor sensitivity and specificity 
(25). Serum cobalamin may be decreased and serum folate may be increased in animals 
with SIBO. If both serum vitamin concentrations are altered this is highly suggestive of 
SIBO. Aberrations in the small intestinal microflora may lead to increased competition 
for cobalamin resulting in decreased absorption. Bacteroides spp. are the principle 
organisms involved in cobalamin competition since they can utilize cobalamin-intrinsic 
factor complexes, while other bacteria can only bind free cobalamin, which is present in 
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lower concentrations in the gut. The reported sensitivity of serum cobalamin 
concentration for the diagnosis of SIBO ranges between 25 to 55% (25). Bacteria present 
in the distal small intestine and large intestine produce large quantities of folate, which is 
excreted in feces. Folate carriers responsible for folate uptake are located exclusively in 
the proximal small intestine and thus folate produced in distal sections of the intestine 
will not be absorbed.  If folate producing bacteria migrate upwards into the proximal 
small intestine, folate of bacterial origin can be absorbed by the host resulting in elevated 
serum folate concentrations. The reported sensitivity of serum folate concentration for 
the diagnosis of SIBO in dogs ranges from 50 to 66% (25). Dogs with exocrine 
pancreatic insufficiency (EPI) have a decreased secretion of antibacterial products with 
subsequent small intestinal bacterial overgrowth. As a consequence, dogs with EPI often 
have increased serum folate concentrations.  
Serum unconjugated cholic acid concentration (SUCA). Measurement of 
SUCA allows indirect assessment of the metabolic activity of the small intestinal 
microflora (57). After feeding, gallbladder contractions leads to release of conjugated 
bile acids, the principal ones in dogs being cholic acids, into the intestinal lumen where 
they facilitate fat absorption. Because of their relatively hydrophilic nature, conjugated 
bile acids undergo only minimal passive intestinal reabsorption and more than 90% of 
conjugated bile acids are absorbed in the distal ileum through specific transporters and 
subsequently undergo an enterohepatic circulation. Only a small portion of conjugated 
bile acids will reach the colon and will be deconjugated by the resident colonic bacteria. 
Bacteria present in the lumen of the small intestine can deconjugate bile acids through 
the action of deconjugases, a feature unique to bacteria (66). Unconjugated bile acids are 
readily absorbed by passive diffusion and transported to the liver (81). Hepatic clearance 
of unconjugated bile acids during “first-pass” circulation is less efficient when compared 
to that of conjugated bile acids, so that 50% of the unconjugated bile acids remain in 
serum where they can be measured by gas chromatography and mass spectrometry. 
Because deconjugation of bile acids in the small intestine is unique to bacteria, 
measurement of unconjugated bile acid and more specifically cholic acid concentration 
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in serum is considered an index of bacterial activity in the small intestine (57). The 
SUCA test has been validated for the use in dogs with a reported initial sensitivity of 
80% (57). In recent studies, however, the sensitivity and specificity of SUCA for dogs 
suspected of having SIBO was reported to be much lower and further studies will be 
required in order to conclusively determine clinical utility of SUCA for dogs with 
suspected SIBO (25).  
Other tests that are based on the deconjugation of bile acids are the 14C- and the 
13C-glycocholic acid test that have been used to diagnose small intestinal bacterial 
overgrowth in humans (71, 93). The 13C-glycocholic acid test is based on deconjugation 
of the naturally occurring bile acid glycocholic acid by intestinal bacteria. 13C-
glycocholic acid (GCA) is the glycine conjugate of cholic acid. One carbon of the 
glycine portion is labeled with 13C, a stable carbon isotope. After oral administration, 
GCA reaches the small intestine where it enters the endogenous bile acid pool and 
undergoes enterohepatic recirculation. Bacteria present in the small intestine are capable 
of deconjugating the 13C-glycine portion from the core bile acid. The 13C-glycine is 
metabolized by intestinal bacteria and 13C is released as 13CO2. The 13C diffuses into the 
blood where it may be transported in three different forms, dissolved in the blood, bound 
to hemoglobin, and as bicarbonate. The 13CO2 can be quantified in blood samples or is 
eventually exhaled and can then be quantified in breath samples by fractional mass 
spectrometry (16, 61, 71).  
HYPOTHESES AND SPECIFIC OBJECTIVES 
The hypotheses of this study are 1) that molecular methods may be used to 
evaluate bacterial diversity in the canine intestinal tract and 2) that indirect serum 
markers of canine intestinal microbial biomass and metabolic activity are sensitive 
enough to detect changes in the composition of the canine intestinal microflora. 
The objectives of the proposed research project in order to prove or disprove 
these hypotheses were 1) to develop a molecular fingerprinting technique for the 
qualitative assessment of bacterial diversity in the canine intestinal tract, 2) to evaluate 
the variation of the small intestinal microflora during repeated sampling using molecular 
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fingerprinting, 3) to evaluate qualitative differences in intestinal bacterial diversity 
between individual dogs and between different compartments of the intestinal tract 
within individual dogs using molecular fingerprinting, 4) to identify bacterial species 
present in the canine intestinal tract by direct sequencing of the 16S rRNA gene, 5) to 
develop a 13C-glycocholic acid blood test as a minimally invasive marker for assessment 
of bacterial biomass and it’s metabolic activity in the canine small intestine, and 6) to 
evaluate changes in indirect markers of the intestinal microflora after antibiotic therapy. 
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CHAPTER II 
 
APPLICATION OF MOLECULAR FINGERPRINTING FOR QUALITATIVE 
ASSESSMENT OF SMALL INTESTINAL BACTERIAL DIVERSITY IN DOGS* 
OVERVIEW 
The aims of this study were to evaluate the use of molecular fingerprinting for 
assessment of bacterial diversity in canine duodenal juice and to evaluate the variation in 
small intestinal microflora at repeated sampling. Two groups of dogs (n = 14) were used. 
Duodenal juice was collected from 8 dogs euthanatized for an unrelated project (group 
1). Duodenal juice was also collected endoscopically from 6 dogs at weekly intervals for 
a total of 3 weeks (group 2). The variable V6-V8 region of bacterial 16S ribosomal DNA 
was amplified and PCR amplicons separated by denaturing gradient gel electrophoresis 
(DGGE). The reproducibility of DGGE profiles, and variations in bacterial diversity 
between dogs, was evaluated by comparing similarity indices (Dice’s coefficient, 100% 
represents complete identity) of DGGE profiles from group 1 dogs. Weekly variations in 
small intestinal flora were evaluated by comparison of DGGE profiles from different 
time-points within the same individuals in group 2. Mean±SD similarity of DGGE 
profiles of duodenal juice between the dogs in group 1 was 38.3 ± 15.7% (range: 12.5-
76.65%). There was a significantly higher variation in DGGE profiles between different 
dogs than between duplicates obtained from the same dog (p<0.0001).  
 
__________________          
*Reprinted with permission from Suchodolski JS, Ruaux CG, Steiner JM, Fetz K, and Williams DA. 
Application of molecular fingerprinting for qualitative assessment of small intestinal bacterial diversity in 
dogs. 2004. J. Clin. Microbiol. 42:4702-4708.  
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DGGE profiles from samples collected at different time-points varied within individuals, 
possibly due to variation over time or slight variation in sampling location. DGGE 
profiles indicate that dogs have a highly diverse small intestinal microflora, with marked 
differences between individual dogs.  
INTRODUCTION 
The domestic dog plays several important roles in modern human society. Dogs 
are commonly used as a model species for biomedical research, as well as being 
commonly kept as pets. The normal canine small intestinal microflora is not well 
characterized. Previous studies aiming to characterize the canine small intestinal 
bacterial flora have focused on the enumeration and identification of bacterial species 
from direct cultivation of duodenal juice (5, 78, 106). This technique is considered to be 
the gold standard for the diagnosis of small intestinal bacterial overgrowth (SIBO) in 
dogs. Bacterial culture, however, has limitations for assessing bacterial diversity in the 
gut. Samples of duodenal juice must be processed immediately in order to accurately 
represent the aerobic and anaerobic microbial flora of the small intestine. Thus, an on-
site microbiology laboratory is required in order to obtain reliable bacterial counts when 
culturing duodenal juice. It is increasingly recognized that the majority of microbial 
species present in biological samples escape identification by use of standard culture 
techniques alone (1, 9, 48, 49, 70, 96). Studies using a molecular biological approach, 
based on identification of 16S ribosomal RNA (rRNA) or 16S ribosomal DNA (DNA 
encoding the16S rRNA), have identified a greater number of bacterial species when 
compared to standard culture techniques, indicating that only a small proportion of 
bacterial species are cultivable with standard bacterial culture techniques (37, 70, 96). It 
has been estimated, for example, that 60 to 80% of bacterial organisms present in the 
gastrointestinal tract of humans and pigs have not yet been cultivated (48, 49).  Based on 
these studies, it is very likely that a culture-dependent approach underestimates the 
bacterial diversity found in the small intestinal fluid of dogs, and an approach based on 
molecular fingerprinting techniques may identify greater small intestinal bacterial 
diversity in the domestic dog than previously reported.   
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Molecular fingerprinting techniques are commonly used to illustrate the genetic 
diversity in a complex microbial community (49, 90). Amplification of 16S rDNA with 
subsequent separation of amplicons by denaturing gradient gel electrophoresis (DGGE) 
has been used for assessment of bacterial diversity in environmental samples (63). The 
principle of DGGE is based on the decreasing electrophoretic mobility of double-
stranded DNA molecules when they are partially melted (64). Briefly, DNA is extracted 
from biological samples, and 16S rDNA amplified using primers that target conserved 
regions (located up- and downstream of variable regions) within the gene encoding 16S 
rRNA. This approach allows amplification of unknown bacterial species. The mixture of 
PCR products, all approximately of the same length, are subsequently separated on a 
polyacrylamide gel containing a linear gradient of DNA denaturants (63). Sequence 
differences in the double stranded DNA influence the melting behavior of the PCR 
amplicons and, therefore, PCR amplicons with different sequences will stop migrating at 
different positions in the gel.  This results in separation of amplicons, and the pattern of 
separated bands illustrates the bacterial diversity in the sample.     
The aims of this study were to evaluate the utility of DGGE fingerprinting for the 
qualitative assessment of bacterial diversity of the canine small intestinal microflora, and 
to evaluate weekly variations in small intestinal bacterial diversity. 
MATERIALS AND METHODS 
Sample material. Duodenal juice samples were collected from 2 groups of 
research dogs, all with no clinical signs of gastrointestinal disease. The protocol for 
sample collection was approved by the University Laboratory Animal care committee at 
Texas A&M University (AUP #2002-103). Group 1 consisted of 8 Hound dogs (4 male, 
4 female) that were euthanatized as part of an unrelated research project. The mean age 
was 3.9 years (range: 2.5–6.0 years). All dogs were housed in the same environment and 
fed the same regular canine maintenance diet. Food was withheld for 24 hours before 
euthanasia. Samples were collected in duplicate from each dog and treated as 
independent samples to evaluate the reproducibility of the DNA extraction, amplification 
of bacterial DNA by polymerase chain reaction (PCR), and the separation of amplicons 
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by DGGE. Immediately after euthanasia the abdominal cavity was opened, the 
duodenum isolated, and two samples, each of approximately 0.5 ml of duodenal juice, 
were collected from approximately the same collection site by needle aspiration using a 
sterile 16-gauge needle attached to a sterile 3-ml syringe.  Group 2 consisted of 6 
healthy research Beagles enrolled in an unrelated research project that required weekly 
anesthesia. Mean age of these dogs was 5.2 years (range: 2-6.8 years). These dogs were 
housed in the same environment and fed a regular canine maintenance once daily. Food 
was withheld for 24 hours before induction of anesthesia on each study day. On the first 
day of the study serum was obtained and serum cobalamin, serum folate, serum trypsin-
like immunoreactivity (TLI), and serum unconjugated cholic acid (SUCA) 
concentrations were evaluated to screen for gastrointestinal disease. On each study day, 
dogs were anesthetized and approximately 0.5 ml of duodenal juice was aspirated using 
a sterile syringe attached to a sterile, 1 mm wide, 150 cm tube introduced through the 
working channel of an endoscope (Flexible endoscope, Olympus, Melville, NY). The 
collection site was approximately 10 cm distal to the major duodenal papilla. Between 
each dog, the endoscope was cleaned (Megazyme, PEA Products Inc., Hunt Valley, 
Mass.) and disinfected (Cidex, Advanced Sterilization Products, Irvine, Calif.) according 
to the manufacturer’s instructions. This sampling procedure was repeated once a week 
for a total of 3 weeks (samples 1, 2, and 3). In week 3, in addition to sample 3 a second 
sample of duodenal content was collected using a disposable sterile cytology brush 
(Disposable Cytology Brushes, 1.7 mm x 160 cm, Horizons International Corp., Puerto 
Rico) introduced through the working channel of the endoscope (sample 3A).  
Storage of samples. All samples were immediately transferred to sterile 
cryotubes (Cryule 2 ml, Wheaton, Millville, NJ), snap-frozen in liquid nitrogen, and 
stored at -80ºC until further analysis.   
Extraction of DNA. To each sample of duodenal juice 500 µl of cell lysis 
solution (Puregene® cell lysis solution, Gentra Systems, Minneapolis, Minn.), 200 µl of 
buffer saturated phenol:chloroform:iso-amylalcohol (ratio 25:24:1, pH 7.2), and 300 µl 
of 0.1 mm zirconia beads (BioSpec Products Inc., Bartlesville, Okla.) were added. The 
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tubes were positioned horizontally on a vortex adapter (Ambion Inc., Austin, Tex.) 
mounted on a standard vortexer and the mixture was vortexed for 5 minutes at maximum 
speed. The tubes were centrifuged for 7 min at 12,000 X g at 4ºC and the supernatant 
transferred to a new, sterile, cryotube. Then 700 µl of phenol:chloroform:iso-
amylalcohol was added, the tube vortexed for 30 sec and centrifuged for 20 min at 
12,000 X g at 4ºC. The aqueous phase was transferred into a new sterile cryotube. To 
increase the DNA yield, 200 µl of buffer (10 mM Tris-HCL, 1 mM EDTA, [pH 8.5]) 
was added to the remaining phenol and organic phase, the above described extraction 
procedure repeated, and both aqueous phases so obtained were combined. To remove 
RNA, 5.2 U of RNAse (Puregene® RNAse, Gentra Systems) was added to the solution 
and incubated at 37ºC for 30 minutes. The RNAse was removed by 
phenol:chloroform:iso-amylalcohol extraction as described above. The aqueous phase 
containing DNA was mixed with 0.5 volumes of 100% ethanol and applied to 
commercially available spin columns (GenElute Bacterial Genomic DNA Kit, Sigma 
Chemicals, St. Louis, Mo.). Bound DNA was washed and eluted according to the 
manufacturer’s instructions. Purified DNA was stored at -20ºC until further use. A 
negative control, containing H2O instead of sample, was purified parallel to each 
extraction batch to screen for contamination of extraction reagents. 
PCR amplification of the V6-V8 region of 16S rDNA. Isolated DNA was 
subsequently used as a template to amplify the variable V6 to V8 region of 16S rDNA 
with universal bacterial primers F-968-GC (5’-GC-
clamp+GAACGCGAAGAACCTTAC-3’) and R-1401 (5’-GGTGTGTACAAGACCC-
3’) (100).  The GC-clamp  (CGCCCGGGGCGCGCCCCGGGCGGGGCGGGGGCACG 
GGG), incorporated into the forward primer, prevents complete dissociation of the DNA 
double strand during the following DGGE analysis (64). The amount of DNA was 
quantified by measuring the absorbance at 260 nm. The reaction mixture (25 µl) 
consisted of reaction buffer (GeneAmp 10xPCR Gold buffer, Applied Biosystems, 
Foster City, Calif.) (final concentrations 15 mM Tris-HCl, 50 mM KCl, 3mM MgCl2, 
[pH 8.0]), 1.25 U Taq DNA polymerase (Amplitaq Gold® LD, Applied Biosystems), 
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250 µM of each deoxynucleoside triphosphate (dNTP), 0.24 µM of both primers, and 
100 ng of DNA template. A negative PCR control, containing H2O instead of the DNA 
template, was included to screen for contamination of PCR reagents. The samples were 
amplified in a thermocycler (Mastercycler Gradient, Eppendorf AG, Hamburg, 
Germany) using a touchdown PCR protocol: initial denaturation step at 94ºC for 3 min; 
9 touchdown cycles (denaturation at 94ºC for 30 sec, annealing for 30 sec, extension at 
68ºC for 1 min) with annealing temperature decreasing 1ºC per cycle from 62ºC to 54ºC; 
25 cycles at 54ºC annealing temperature (denaturation at 94ºC for 30 sec, annealing for 
30 sec, extension at 68ºC for 1 min), and final elongation step at 72ºC for 10 min. The 
purity and correct size of resulting PCR amplicons (approx. 450 bp) were assessed on 
1% agarose electrophoresis gels, stained with ethidium bromide (staining for 15 min and 
destaining in H2O for 60 min) and visualized under UV light.   
DGGE analysis of PCR amplicons. DGGE analysis was performed on a DGGE 
system (DCode™, Biorad Laboratories, Hercules, Calif.) according to the 
manufacturer’s instructions. PCR amplicons were applied to 16x16 cm, 8% (wt/vol) 
polyacrylamide gels (acrylamide-bisacrylamide, 37.5:1) in  TAE buffer (40 mM Tris-
acetate, 1 mM Na2EDTA, [pH 7.4]) with a linear denaturing gradient of 35% to 70% 
(100% of denaturant was defined as 7 M Urea and 40% (vol/vol) deionized formamide). 
To standardize DGGE gels a commercially available DNA ladder (DNA ladder (log2), 
New England Biolabs Inc., Beverly, Mass.) was loaded as a marker. Electrophoresis was 
performed in TAE buffer at 60ºC for 16 hours at 70 V. Gels were stained with ethidium 
bromide for 12 min and subsequently destained in H2O two times for 30 minutes. Gels 
were scanned (AlphaImager, Alpha Innotech Corporation, San Leandro, Calif.) and 
banding patterns were analyzed using gel analysis software (Bionumerics 3.0, Applied 
Maths, Austin, Tex.). Similarity indices between the banding patterns were calculated 
using Dice’s similarity coefficient (Dsc = [2j/(a+b)]x100; where a = number of DGGE 
bands in lane 1, b = number of DGGE bands in lane 2, and j = number of common 
DGGE bands; Dsc = 100% demonstrates complete identity) (56). Dendrograms, showing 
clustering according to the similarity of banding patterns of individual samples, were 
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constructed by the unweighted pair group method using arithmetic averages (UPGMA) 
(23).  
RESULTS 
Group 1. The variable V6 to V8 region of 16S rDNA could be successfully 
amplified from all 16 samples. DGGE profiles illustrating the bacterial diversity in 
duodenal juice and the variation in bacterial diversity between duplicates and between 
dogs are illustrated in figure 1. Similarity indices of DGGE profiles between duplicates 
collected from the same collection site from each dog were 66.7, 76.9, 80.0, 92.3, 94.7, 
96.3, 100.0, and 100.0 (mean ± SD: 88.4 ± 12.3%). The mean ± SD similarity index of 
DGGE profiles of duodenal juice between the 8 dogs was 38.3 ± 15.7% (range: 12.5-
76.6%). Student’s t-test revealed that there was a significantly higher variation in DGGE 
profiles between different dogs than between duplicates obtained from the same dog 
(p<0.0001; Fig. 2).  
Group 2. From 18 potential time-points (3 sampling periods in six dogs) 17 
samples of duodenal content were obtained by aspiration. As no duodenal juice could be 
aspirated in one dog at time-point 3 (sample 3) the corresponding sample of duodenal 
content collected at the same time-point using the cytology brush (sample 3A) was 
excluded from further statistical analysis. In another dog no 16S rDNA could be 
amplified from the DNA extracted at time-point 1. DNA extracted from all other 
samples was successfully amplified. DGGE analysis revealed a sizeable variation in 
similarity indices between the different time-points within the same individuals (Fig. 3). 
The mean ± SD similarity between the different time-points (samples 1, 2, and 3) within 
individual dogs was 38.3 ± 13.3%. The mean similarity between samples taken in week 
3 (sample 3) and their corresponding samples taken using the cytology brush (sample 
3A) was 62.6 ± 13.4% (Fig. 4). There was a significantly higher variation between the 
different time-points in individual dogs than between samples taken at the same time-
point 3 (sample 3 and sample 3A; p = 0.003; Fig. 5). 
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FIG 1. DGGE profiles illustrating small intestinal bacterial diversity in 8 dogs (1-8, in 
duplicate). Samples were collected in duplicate from approximately the same collection 
site in each dog and treated as independent samples to evaluate the reproducibility of 
DGGE profiles.  (M = marker) 
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FIG 2. Dendrogram (UPMGA) generated from DGGE profiles obtained from canine 
duodenal juice from 8 dogs (dogs 1-8 of group 1, in duplicate) representing similarities 
in banding pattern between duplicates obtained from each dog and between different 
dogs. Mean±SD similarity index between the 8 dogs was 38.3±15.7% (range: 12.5-
76.65%). Mean±SD similarity index between the duplicates from each dog was 
88.4±12.3%. There was a significantly higher variation in DGGE profiles between dogs 
than between duplicates obtained from the same dog (p<0.0001). 
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FIG 3. DGGE profiles of duodenal juice collected endoscopically in 6 dogs (dogs A-F) 
illustrating a sizeable variation in duodenal microflora between the different time-points 
within the same individual. Samples were collected by aspiration once weekly (samples 
1, 2, and 3). In week 3 a second sample was collected using a cytology brush (3A). 
Samples taken at the same time-point from each dog (sample 3 and 3A) showed the 
highest similarity. No duodenal juice could be aspirated from dog C on week 3. No PCR 
amplicon could be generated from dog F on week 1. (M=marker) 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG 4. Dendrogram (UPGMA) generated from DGGE profiles representing similarities 
in banding patterns between the two samples obtained by different techniques in week 3. 
The mean similarity between aspirated samples (sample 3) and their corresponding 
samples taken using the cytology brush (sample 3A) was 62.6±13.4%.  
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FIG 5. Dendrogram (UPGMA) generated from DGGE profiles representing similarities 
in banding patterns in samples from all time-points collected endoscopically in 6 dogs 
(dog A-F). The mean±SD similarity between the different time-points (samples 1, 2, and 
3) within individual dogs was 38.3±13.3%. There was a significantly higher variation 
between the different time-points in individual dogs than between samples taken at the 
same time-point by two different techniques (sample 3 and sample 3A; p=0.003).  
 
DISCUSSION 
Traditionally, assessment of the canine small intestinal microflora has been based 
on identification and enumeration of intestinal bacteria by bacterial culture (5, 78, 106). 
It is becoming increasingly apparent, however, that only a proportion of bacterial species 
present in the gut can be identified using traditional bacterial culture techniques (1, 9, 48, 
49, 70, 96). Reasons for this inability to culture many bacterial species include non-
viable or stressed microorganisms, obligate requirements for coexisting flora or host-
derived products, bias due to selectivity of culture media, and our lack of knowledge 
regarding essential nutrients for some bacterial species (15).  
 25 
Molecular approaches, based on assessment of human fecal samples, have revealed that 
the gastrointestinal microflora is more complex than previously documented (96). Based 
on sequence analysis of PCR products new bacterial species, not previously detected by 
cultivation have been identified in fecal samples of humans and the gastrointestinal tract 
in pigs (48, 49). Sequencing of single PCR clones, however, is a laborious and expensive 
procedure and not well suited to studying complex microflora or microbial dynamics due 
to environmental changes. Molecular fingerprinting techniques (eg, DGGE) allow rapid 
assessment of the predominant bacterial species present in a sample. The DGGE profile 
typically represents up to 99% of the total bacterial community present in a biological 
sample (63). While molecular fingerprinting does not allow immediate discrimination 
between bacterial species, is does allow simultaneous analysis of multiple samples and, 
thus, direct comparison of microbial communities from different samples (63). 
Molecular fingerprinting also allows the study of changes in individual microbial 
communities over time.  
In this study we have demonstrated that DGGE profiles can serve as a rapid and 
reproducible tool for qualitative assessment of small intestinal bacterial diversity in 
dogs. Results were typically obtained within 48 hours of sample collection. Duplicates 
of duodenal juice collected by laparotomy and needle aspiration from the same dog 
showed a mean similarity of 88%. This reproducibility is similar to previously reported 
DGGE profiles obtained from fecal samples, showing a reproducibility of 91% (89). The 
mean similarity of DGGE profiles from duplicates collected from the same dog was 
significantly higher than the mean similarity of DGGE profiles between dogs. The mean 
similarity of DGGE profiles between all 8 dogs in group 1 was 38%, indicating that dogs 
have a highly diverse duodenal microflora with marked differences between individual 
dogs. This is consistent with previous reports suggesting, based on bacterial culture, that 
the canine small intestinal microflora appears to be very variable between dogs (41). To 
our knowledge, molecular fingerprinting illustrating small intestinal bacterial diversity in 
dogs has not been reported in the literature previously. One study examined the 
influence of age, breed, and dietary fiber on bacterial diversity in fecal samples of dogs 
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using DGGE profiles (88) and reported that individual dogs have stable and unique fecal 
flora.  
While DGGE profiles of duodenal juice collected by laparotomy and needle 
aspiration showed high reproducibility, the invasiveness of this sampling technique has 
obvious disadvantages. Studies of temporal variation in small intestinal bacterial 
diversity, and collection of clinical case material, would be difficult using this method of 
collection. Therefore, a less invasive collection technique such as endoscopic collection 
of duodenal juice is preferable. Laparotomy with needle aspiration and endoscopic 
collection of duodenal juice showed significant correlation, based on qualitative and 
quantitative bacterial culture (42, 69). We evaluated two different endoscopic collection 
methods, both utilizing the working channel of an endoscope: aspiration of duodenal 
juice through a sterile plastic tube and the collection of duodenal content using a 
cytology brush. We also evaluated weekly variations in the DGGE profiles. One 
problem we encountered in evaluating reproducibility of endoscopic sampling is the 
limited amount of duodenal juice that can be collected using the aspiration technique. At 
one time-point no duodenal juice could be collected at all in one of the dogs. While it 
was possible to collect approximately 0.5 ml of duodenal juice in all other dogs at all 
other time-points, not enough duodenal juice was available to collect a duplicate sample 
at the same time-point. Therefore, we were unable to evaluate the reproducibility of 
DGGE profiles from duodenal juice collected at the same time-point by endoscopic 
aspiration. In addition, in order to collect 0.5 ml of duodenal juice, a considerable 
amount of time (approximately 10-20 min) had to be invested per dog, making the 
collection of duodenal juice by endoscopic aspiration rather impractical for routine 
clinical application. Additionally, no PCR amplicon could be amplified from one sample 
obtained by endoscopic aspiration. This inability to amplify DNA is more likely due to 
carry-over of inhibitory substances during DNA extraction rather than a causal effect of 
the collection technique. Exocrine pancreatic secretions contain considerable amounts of 
ribonucleases that might have not been sufficiently eliminated during DNA extraction, 
these substances might have interfered in the subsequent PCR reaction (44). Based on 
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our experience during the development of the protocol for the DNA extraction from 
duodenal juice, it is crucial to obtain highly pure DNA. 
The use of a cytology brush introduced through the working channel of an 
endoscope may be a superior method of sampling the duodenal contents for several 
reasons: it would make collection of samples easier, faster, and, if taken in the same 
fashion, also more reproducible, as a more constant amount of sample would be 
collected. Also, in this study a PCR amplicon could be generated from DNA extracted 
from all cytology brushes. However, relatively few samples obtained by cytology brush 
were analyzed and further samples collected using this collection method need to be 
evaluated.  
Samples collected in the same dog at the same time-point either by aspiration or 
cytology brush showed 62% similarity. While this similarity was significantly higher 
than the similarity between different time-points in individual dogs, it was significantly 
lower than the similarity of duplicate duodenal juice collections using a syringe in the 
group 1 dogs. This could be partially explained by the differences in bacterial 
populations present in the intestinal lumen vs. adherent to the intestinal mucosa. 
Quantitative and qualitative differences in microbial species between intestinal lumen 
and intestinal biopsy samples have been found based on bacterial culture (18). However, 
we speculate that collection using a cytology brush differs from an intestinal biopsy 
sample, since the collected sample consists mostly of intestinal fluid and some 
superficial mucosal cells. Therefore, this collection technique would represent a mixture 
of both microbial populations and proper standardization of the sampling technique 
would allow comparison of the microbial community between healthy and diseased 
individuals.  
The fecal microflora has been reported to be stable over time when analyzed by 
DGGE (88). In contrast, results of studies using bacterial culture sampling at different 
time-points suggest significant qualitative and quantitative fluctuations in the small 
intestinal microflora (18, 32, 107).  These studies are hampered by the fact that the 
repeated collection occurred either at long intervals (18, 107), or has been performed in 
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dogs with IgA deficiency (107) or dogs that had undergone surgery that might have 
influenced the small intestinal microflora (32). The authors of these studies also do not 
exclude the possibility that either culture techniques or ingested bacteria might have led 
to the observed variation.  
In this study, samples of duodenal juice collected at weekly intervals in 
individual dogs showed sizeable variation in their banding patterns. Since, for reasons 
described above, no duplicate samples could be obtained at the same time-point by 
aspiration it is difficult to conclude if this variation was due to sampling technique or an 
inherent variation of the small intestinal microflora over time. However, in dogs from 
group 2 approximately the same volume of duodenal juice was analyzed as in the dogs 
from group 1, where the duplicates showed 88% reproducibility. This would suggest that 
the variation in similarity between the different time-points is less likely due to sampling 
method variation, instead reflecting a genuine variation over time. The observation  that 
“duplicate” samples collected at the same time-points (sample 3 and 3A), albeit using 
two different collection techniques, showed significantly less variation than the weekly 
variation further suggests a genuine variation in the small intestinal microflora over time.  
However, it can not be definitively concluded from this study that the observed variation 
at different time-points is solely due to changes in the small intestinal microflora over 
time. We attempted to collect samples from approximately the same sampling site on 
each study day using the distance markings located on the outside of the endoscope. 
However, it is possible that the bacterial composition differs between samples that are 
taken from locations that are only a short distance apart from each other. This variation 
of the small intestinal microflora obtained during repeated sampling, regardless of the 
underlying cause, needs to be taken into consideration when collecting clinical samples.  
Using DGGE profiles, we have shown that dogs have a highly diverse bacterial 
microflora in the small intestine. However, important limitations of this PCR based 
approach that might interfere with the interpretation of our results need to be 
acknowledged. Molecular detection techniques do not generally have the ability to 
determine whether an organism is dead or alive, and the DNA collected may at least in 
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part be due to orally ingested microbial material (15). No information is available about 
the persistence of DNA in the canine intestine. Pancreatic juice contains considerable 
amounts of DNAse, which may degrade DNA present in the small intestinal lumen (44). 
Studies in mice have also shown that unfragmented aliquots of ingested DNA could be 
recovered from the small intestine for only up to 30 min after feeding, 18 hours after 
feeding no foreign DNA could be detected in the lumen of any gut compartment by 
Southern hybridization (68). Since food was withheld for 24 hours in all dogs in this 
study, it appears unlikely that ingested DNA would have interfered with our results, 
assuming that all dogs had normal intestinal motility. It is also assumed that DNA is 
equally extracted from all bacterial species. PCR may exhibit bias, by targeting only 
predominant species that constitute more than 1% of the microflora (63). PCR, 
especially at higher cycle numbers, can introduce mutations, chimeras, and 
heteroduplexes (74). Some bacterial species are known to have multiple copies of the 
16S rRNA gene, making a quantitative interpretation questionable. It has also been 
shown that DGGE has a limited resolving power for some PCR amplicons as amplicons 
with closely related sequences may co-migrate and denature at the same time. Thus, 
bands on DGGE may be comprised of several amplicons, underestimating bacterial 
diversity. Due to the exponential nature of PCR amplification, PCR is extraordinarily 
prone to iatrogenic contamination, the use negative PCR controls is crucial to monitor 
for contamination. Despite these limitations, DGGE profiles have been shown to be a 
powerful tool for assessment of bacterial diversity in environmental samples (64).    
The molecular approach described in our study can facilitate identification of 
bacterial species not previously cultured from the canine small intestine. Further 
elucidation of the complexity of the small intestinal microflora will potentially allow us 
to understand the host-bacteria interactions leading to disease. The clinical significance 
of the diverse small intestinal microflora in dogs, and the alterations in bacterial 
diversity that may be present with gastrointestinal disease needs to be further explored.  
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CHAPTER III 
ASSESSMENT OF QUALITATIVE VARIATION IN INTESTINAL 
MICROFLORA IN DIFFERING COMPARTMENTS OF THE CANINE 
INTESTINAL TRACT USING A MOLECULAR FINGERPRINTING 
TECHNIQUE* 
OVERVIEW 
The aim of this study was to evaluate qualitative variation in bacterial microflora 
in different compartments of the canine intestinal tract using a molecular fingerprinting 
technique. Intestinal content was collected from the duodenum, jejunum, ileum, colon, 
and rectum of 14 adult Hound dogs housed under identical conditions and fed identical 
diets. Bacterial DNA was extracted, the variable V6-V8 region of 16S rDNA (gene 
coding for 16S ribosomal RNA) was amplified using universal bacterial primers, and 
PCR amplicons were separated by denaturing gradient gel electrophoresis (DGGE). 
Variation in the intestinal microflora between different compartments of the intestine 
within individual dogs, and between all dogs, was assessed based on similarity indices of 
DGGE banding patterns. Bacterial diversity was assessed by calculating Simpson’s 
diversity index, the Shannon-Weaver diversity index, and evenness. DGGE profiles 
indicated marked differences when individual compartments were compared between 
dogs (range 25.6-36.6%). There was also a sizeable variation in the microflora between 
different intestinal compartments within individual dogs (range: 36.7–57.9%). 
Neighboring compartments showed significantly higher similarity than non neighboring 
compartments (p<0.0001). Diversity indices were significantly higher in the large 
intestine than the small intestine (p<0.01).  
__________________          
*Reprinted with permission from Suchodolski J.S., Ruaux C.G., Steiner J.M., Fetz K., and Williams 
D.A. 2005. Assessment of qualitative variation in intestinal microflora in differing compartments of the 
canine intestinal tract using a molecular fingerprinting technique. Am. J. Vet. Res. 66:1556-1562. 
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The results indicate that dogs have a complex intestinal microflora with marked 
differences between individual dogs. Differing intestinal compartments within individual 
dogs appear to host unique microflora. Assessment of the microflora present in a fecal 
sample may not yield accurate information about the composition of the intestinal 
microflora in other compartments of the canine gut. 
INTRODUCTION 
Dogs are commonly used as a model species for biomedical research, as well as 
being commonly kept as pets. The intestinal bacterial flora has an important influence on 
the health of the individual animal, while alterations in this flora have been associated 
with intestinal disease. Previous studies aiming to characterize the canine intestinal 
bacterial flora have focused on the enumeration and identification of bacterial species 
from direct cultivation of either duodenal juice or fecal samples (5, 78, 106). Relatively 
little is known about the composition of the bacterial microflora in other compartments 
of the canine intestine, and limited data, based on bacterial culture, are available that 
evaluate differences in the microflora between dogs or between intestinal compartments 
within dogs (10, 17).  
Bacterial culture has limitations for assessing bacterial diversity in the gut. 
Samples must be processed immediately in order to accurately represent the aerobic and 
anaerobic microbial flora present in the gastrointestinal tract. The intestinal tract harbors 
many anaerobic bacteria, which are more prone to damage during handling of samples. 
Also, identification of bacteria is based on phenotypic identification systems, this may 
lead to limitations in accurately characterizing all microorganisms in a given sample. It 
is also increasingly recognized that the majority of microbial species present in 
biological samples escape identification by use of standard culture techniques alone (1, 
9, 48, 49, 70, 96). It has been estimated that approximately 60-80% of organisms present 
in the gastrointestinal tract of various species have not yet been cultivated (48, 49). 
Studies using a molecular approach based on identification of 16S ribosomal RNA 
(rRNA) or 16S rDNA (DNA coding 16S rRNA) have identified a greater number of 
bacterial species, when compared to standard culture techniques (37, 70, 96). 
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Sequencing of single PCR clones is a laborious and expensive procedure and thus not 
well suited to study complex microflora or microbial dynamics due to environmental 
changes. Molecular fingerprint techniques are commonly used to illustrate the genetic 
diversity in a complex microbial community (49, 90). Polymerase chain reaction of 16S 
rDNA, with subsequent separation of amplicons by denaturing gradient gel 
electrophoresis (DGGE) based on sequence differences, has been shown to be a useful 
tool for assessment of bacterial diversity in environmental samples as well as in a 
mixture of known bacterial species (63, 100). While molecular fingerprints do not allow 
direct identification of bacterial species, they allow simultaneous analysis of multiple 
samples and, thus, direct comparison of microbial communities from different samples 
(63). In a previous study our group has demonstrated that endoscopic collection of 
duodenal juice with subsequent assessment of small intestinal bacterial diversity by use 
of a molecular fingerprinting technique is a useful and reproducible tool and warrants 
further investigation in dogs with small intestinal disease (98). 
In a clinical setting the intestinal microflora is typically evaluated by analysis of 
intestinal samples obtained either by endoscopic collection of duodenal juice or by 
collection of fecal samples. For future clinical studies evaluating the intestinal 
microflora using molecular techniques it is necessary to evaluate if the assessment of 
duodenal or fecal samples is representative of the microflora present in other 
compartments of the canine intestinal tract. The objective of this study was to evaluate 
the variation in bacterial microflora in different compartments of the intestinal tract, 
within and between individual dogs, using a molecular fingerprinting technique. 
MATERIALS AND METHODS 
Sample material. Intestinal content was collected from the duodenum, jejunum, 
ileum, colon, and rectum from 14 adult Hound dogs (8 male and 6 female). The mean 
(±SD) age was 3.9 (±1.3) years (range 2.2-6.2 years). All dogs were raised and housed in 
the same environment and fed the same regular canine maintenance diet. These dogs 
were euthanized as part of an unrelated project. The protocol for sample collection was 
approved by the University Laboratory Animal Care Committee at Texas A&M 
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University. In all dogs food was withheld for 24 hours before euthanasia. Immediately 
after euthanasia the abdominal cavity was opened, and the intestines were isolated. 
Intestinal content was collected by needle aspiration of duplicate samples from 
approximately the same collection site in each dog. Approximately 0.5 ml of intestinal 
fluid or, in distal parts of the intestine, solid intestinal content was collected from each 
collection site using a sterile 16 gauge needle attached to a 3-ml syringe or a fecal 
collection tube, respectively. To evaluate the reproducibility of DNA extraction and 
PCR-DGGE, intestinal content obtained from 2 different dogs (referred to as sample A 
and sample B) was homogenized by rigorous vortexing for 20 minutes.  Sample A and 
sample B were then subdivided into 4 aliquots.  
Handling of samples. All samples were immediately transferred into sterile 
cryotubes (Wheaton, Millville, NJ), snap-frozen in liquid nitrogen, and stored at -80ºC 
until further analysis.   
Extraction of DNA. DNA was extracted using a modified bead beating method. 
Briefly, 500 µl of cell lysis solution (Puregene® cell lysis solution, Gentra Systems, 
Minneapolis, Minn.), 200 µl of buffer saturated phenol:chloroform:iso-amylalcohol 
(25:24:1), and 300 µl of 0.1 mm zirconia beads (BioSpec Products Inc., Bartlesville, 
Okla.) were added to each sample. The tubes were positioned horizontally on a vortex 
adapter (Ambion Inc., Austin, Tex.) mounted on a standard vortexer (Vortex Genie-2, 
VWR, West Chester, Pa.) and the mixture was vortexed for 5 minutes at maximum 
speed. Tubes were centrifuged for 7 min at 12,000 x g and the supernatant transferred 
into a new sterile tube. A second phenol:chloroform:iso-amylalcohol extraction was 
performed, and the aqueous phase was transferred into a new sterile tube. RNA was 
removed by 30 min incubation at 37ºC with 5 U of RNAse (Puregene® RNAse, Gentra 
Systems, Minneapolis, Minn.). RNAse was removed by phenol:chloroform:iso-
amylalcohol extraction as described above. The aqueous phase, containing DNA, was 
mixed with 0.5 volumes of 100% ethanol and applied onto commercially available spin 
columns (GenElute Bacterial Genomic DNA Kit, Sigma Chemicals, St. Louis, Mo.). 
Bound DNA was washed and eluted according to manufacturer’s instructions. Purified 
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DNA was stored at -20ºC until further use. A negative control, containing H2O instead of 
intestinal content was purified parallel to each extraction batch to screen for 
contamination of extraction reagents. 
PCR amplification of the V6-V8 region of 16S rDNA. The variable V6 to V8 
region of 16S rDNA was amplified using universal bacterial primers F-GC-968 (5’-GC-
clamp[CGCCCGGGGCGCGCCCCGGGCGGGGCGGGGGCACGGGG]+GAACGCG
AAGAACCTTAC-3’) and R-1401 (5’-GGTGTGTACAAGACCC-3’) (100).  The 
reaction mixture consisted of 1.25 U Taq DNA polymerase (Amplitaq Gold® Low 
DNA, Applied Biosystems, Foster City, Calif.), 1x reaction buffer (Amplitaq Gold® 
reaction buffer, Applied Biosystems, Foster City, Calif.) (15 mM Tris-HCl, 50 mM KCl, 
3mM MgCl2, [pH 8.0]), 250 µM of each deoxynucleoside triphosphate (dNTP), 0.24 µM 
of each primer, and 100 ng of DNA template in a total volume of 25 µl. A negative PCR 
control, containing H2O instead of DNA template, was evaluated to screen for 
contamination of PCR reagents. The samples were amplified in a Mastercycler 
(Mastercycler Gradient, Eppendorf AG, Hamburg, Germany) using a touchdown PCR 
protocol with an initial denaturation step at 94ºC for 3 min, 9 touchdown cycles 
(denaturation at 94ºC for 30 sec, annealing for 30 sec, and extension at 68ºC for 1 min) 
with  annealing temperature decreasing by 1ºC per cycle from 62ºC to 54ºC, 20 cycles 
with an annealing temperature of 54ºC (denaturation at 94ºC for 30 sec, annealing for 30 
sec, and extension at 68ºC for 1 min), and a final elongation step at 72ºC for 10 min. The 
purity of the PCR amplicons were assessed on 1.2% agarose electrophoresis gels stained 
with ethidium bromide and visualized under UV transillumination. The correct size of 
PCR amplicons (approx. 450 bp) and the amount of PCR product were evaluated by 
comparing the band size and the intensity of the bands to commercially available DNA 
markers (DNA ladder (log2), New England Biolabs Inc., Beverly, Mass.). 
DGGE analysis of PCR amplicons. DGGE analysis was performed with the 
Bio-Rad Universal Mutation Detection System (DCode™, Biorad Laboratories, 
Hercules, Calif.). PCR products were applied onto 8% (wt/vol) polyacrylamide gels 
(acrylamide-bisacrylamide, 37.5:1) in  buffer (1x TAE buffer, 40 mM Tris-acetate, 1 
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mM Na2EDTA, pH 7.4) with a linear denaturing gradient of 35% to 70% (100% of 
denaturant is defined as 7 M Urea and 40% (vol/vol) deionized formamide). Samples 
from each individual dog (each compartment in duplicate) were analyzed on one gel. For 
comparison of samples between gels, a commercially available DNA ladder (DNA 
ladder (log2), New England Biolabs Inc., Beverly, Mass.) was loaded as a marker (3 
lanes per gel). Electrophoresis was performed in 1x TAE buffer at 60ºC for 16 hours at 
70 V. Bands were visualized by staining gels with ethidium bromide and viewed by UV 
transillumination.  
Sample analysis. Gel images were digitally captured (AlphaImager, Alpha 
Innotech Corporation, San Leandro, Calif.) and DGGE profiles analyzed using gel 
analysis software (Bionumerics 3.0, Applied Maths, Austin, Tex.). The bands in each 
profile were converted into peak profiles in densitometric curves. The data were used to 
calculate bacterial diversity indices which yield information about species diversity in a 
bacterial community:  Simpson’s reciprocal diversity index, the Shannon-Weaver 
diversity index, evenness were calculated (3). Simpson’s reciprocal diversity index (D) 
was defined as D = 1/∑(n/N)2, where n = the total number of organisms of a particular 
species, and N = the total number of organisms of all species. The Shannon-Weaver 
index (Hs) was defined as Hs = [-∑piln(pi)], where pi is the proportion of individual 
bacteria found in a certain species. A higher value for D and Hs indicates higher 
bacterial diversity in the sample. Evenness (e) describes how uniformly individual 
bacterial species are divided between all species present, and was defined as e = 
Hs/ln(S), where S is the number of total species. Evenness values range between 0 and 1, 
with 1 being complete evenness (i.e. the relative abundance of all species is equal). D 
and Hs were compared between different gut compartments using repeated measures 
ANOVA followed by Tukey’s multiple comparison test. Evenness was compared 
between different gut compartments using the Friedman test followed by Dunn’s 
multiple comparison test. DGGE banding patterns were compared between all samples 
by calculating Dice’s similarity coefficient (Cs=[2j/(a+b)]x100; where a = number of 
DGGE bands in lane 1, b = number of DGGE bands in lane 2, and j = number of 
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common DGGE bands).  A Cs
 
of 100% demonstrates complete identity between two 
DGGE banding patterns (56). 
The reproducibility of PCR-DGGE was evaluated by comparing the mean 
similarity (Cs) of banding patterns between the aliquots obtained from homogeneous 
intestinal content from sample A and B, respectively. The variation in banding patterns 
between different intestinal compartments within and between dogs was calculated by 
comparing the Cs between individual samples. Dendrograms, showing clustering 
according to the similarity of banding patterns of individual samples, were constructed 
by the unweighted pair group method using arithmetic averages (UPGMA) (23). 
Samples belonging to the same cluster were determined by a cluster cutoff algorithm 
based on the Point-Biserial correlation in the Bionumerics software (40). The cophenetic 
correlation coefficient was calculated using Bionumerics software. This coefficient 
estimates the goodness of fit for each subcluster within a dendrogram, a coefficient  > 
0.8 suggests a good fit of the cluster analysis to the data (54). 
RESULTS 
Ileal content could not be obtained from one dog, resulting in a total of 138 
collected samples (14 dogs x 5 collection sites/per dog x 2 replicates). From 2 of these 
138 samples the V6 to V8 region of the 16S rDNA could not be amplified (1.4%): both 
replicates of duodenal content in one dog. The V6 to V8 region of the 16S rDNA was 
successfully amplified in the remaining 136 samples. The mean±SEM similarity (Cs) 
between the banding patterns of the aliquots from homogeneous samples A and sample 
B was 96.2±0.8% and 93.1±1.0%, respectively. There was a sizeable variation in 
banding patterns when individual compartments were compared between individual 
dogs, with Cs ranging from 25.6% (ileum) to 36.6% (colon) (Table 1). There was also 
sizeable variation in similarity of banding patterns between different compartments 
within individual dogs (Table 2). Neighboring compartments had a significantly higher 
similarity than non-neighboring compartments (p<0.0001), with the colon and rectum 
showing the highest similarity (mean±SEM: 57.9±3.0%).  
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The bacterial diversity indices increased gradually down the length of the gut 
(Fig. 6, Table 3) indicating an increase in bacterial diversity and evenness. Bacterial 
diversity indices were significantly higher in both compartments of the large intestine 
compared to the three compartments in the small intestine (Table 4).  
The cluster cutoff method in the Bionumerics software suggested 4 major 
clusters in the dendrogram (Fig. 7). The cophenetic correlation, however, revealed poor 
fit (r=0.65) of the data for these major clusters indicating that these results need to be 
interpreted with caution. There was, however, an obvious trend demonstrating that 
individual dogs tend to have unique bacterial microflora, especially in the large intestine. 
In all dogs (14/14) the similarity between the colonic and rectal banding pattern was 
higher within the individual than when compared to other dogs (cophenetic correlation 
r=1.0 for these samples; Fig. 7).  A similar, but less extensive, trend was noticeable in 
the proximal small intestine (duodenum and jejunum), where 8/14 dogs clustered at least 
with one neighboring compartment (Fig. 7). In contrast, the microflora in the ileum was 
very variable. In a subset of dogs (5/14) the ileal microflora clustered with at least one 
compartment of the small intestine. In another subset (3/14) the ileal microflora clustered 
together with the large intestine, while in 5/14 dogs the ileal microflora did not cluster 
with any compartment from the same dogs (Fig. 7). 
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TABLE 1. Mean similarity (%) of DGGE profiles within each compartment obtained by 
pair-wise comparison between individual dogs. 
 mean Csa SEMb min max 
Duodenum 28.0 2.7 3.8 51.0 
Jejunum 26.8 2.2 7.7 46.3 
Ileum 25.6 2.2 5.7 47.0 
Colon 36.6 2.2 19.1 54.4 
Rectum 36.2 2.3 17.4 51.9 
aDice’s similarity coefficient 
bSEM= Standard error of the mean 
 
 
 
 
 
TABLE 2. Mean similarity (%) of DGGE profiles between different compartments 
within individual dogs. 
 mean Csa SEMb min max 
Duodenum-Jejunum* 43.0 5.0 16.4 74.6 
Duodenum-Ileum 32.5 3.3 12.3 57.1 
Duodenum-Colon 29.0 3.7 10.0 51.9 
Duodenum-Rectum 29.9 3.2 10.6 45.3 
Jejunum-Ileum 36.7 4.4 16.4 66.6 
Jejunum-Colon 28.0 1.9 12.9 40.7 
Jejunum-Rectum 26.8 2.7 9.9 46.0 
Ileum-colon 38.8 4.2 10.0 64.3 
Ileum-Rectum 32.8 3.8 8.4 55.9 
Colon-Rectum 57.9 3.0 37.3 72.8 
*Rows in bold indicate neighboring compartments 
aDice’s similarity coefficient  
bSEM= Standard error of the mean 
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TABLE 3. Bacterial diversity indices (mean±SEM) in different intestinal compartments 
in 14 dogs as indicated by the Simpson diversity index, the Shannon-Weaver 
diversity index, and evenness. 
  Simpson 
diversity index 
Shannon-Weaver 
diversity index 
 
Evenness 
Duodenum 3.94±0.57 1.44±0.15 0.81±0.03 
Jejunum 4.22±0.45 1.52±0.12 0.85±0.03 
Ileum 6.17±1.00 1.79±0.18 0.86±0.03 
Colon 9.33±0.83 2.32±0.11 0.91±0.02 
Rectum 8.49±0.62 2.27±0.07 0.90±0.01 
 
 
 
TABLE 4. P-values for differences in the mean number of bacterial diversity indices, 
between intestinal compartments in the dog. 
 Simpson  
diversity index 
Shannon-Weaver 
 diversity index 
 
Evenness 
Duodenum-Jejunum p > 0.05 p > 0.05 p > 0.05 
Duodenum-Ileum p > 0.05 p > 0.05 p > 0.05 
Duodenum-Colon p < 0.001 p < 0.001 p < 0.001 
Duodenum-Rectum p < 0.001 p < 0.001 p < 0.01 
Jejunum-Ileum p > 0.05 p > 0.05 p > 0.05 
Jejunum-Colon p < 0.001 p < 0.001 p > 0.05 
Jejunum-Rectum p < 0.001 p < 0.001 p > 0.05 
Ileum-colon p < 0.01 p < 0.01 p > 0.05 
Ileum-Rectum p > 0.05 p < 0.01 p > 0.05 
Colon-Rectum p > 0.05 p > 0.05 p > 0.05 
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FIG 6. DGGE profiles illustrating bacterial diversity in different intestinal compartments 
in 4 dogs (gel 1-4). (D=duodenum, J=jejunum, I=ileum, C=colon, R=rectum; m=marker; 
samples loaded in duplicates). Dogs have marked differences in bacterial microflora 
between different intestinal compartments within individual dogs and between dogs. 
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FIG 7-next page.  Dendrogram (UPGMA) based on the Dice coefficient of similarity 
between differing intestinal compartments in dogs. The number next to the intestinal 
compartment indicates the identity of the dog. Branches below the cluster cutoff value 
are shown with dashed lines. Cophenetic correlation coefficients are shown in each 
branch of the dendrogram.  
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DISCUSSION 
In this study we evaluated variation of the intestinal microflora in differing 
compartments of the canine intestinal tract within individuals and between dogs. 
Environmental influences were minimized by housing all dogs in an identical 
environment and feeding the same diet. The results of DGGE analysis suggest marked 
variation in bacterial microflora between individual dogs, and in differing intestinal 
compartments within individual dogs.  
Inter-individual variation of the intestinal microflora has been suggested, based 
on bacterial culture, in the ileum, cecum, and colon of dogs (17). Davis et al. have also 
shown that dogs housed for years in the same environment and fed the same diet have 
marked differences in their microflora (17). While molecular fingerprinting techniques 
have been used to evaluate inter-individual variation in the intestinal microflora in 
various species such as humans (112), dogs (88), and pigs (89), these studies have 
focused predominantly on the microflora present in fecal samples (88, 89, 112). Marked 
differences in the fecal microflora between humans have been observed using 
temperature gradient gel electrophoresis (112). Simpson et al. examined the influence of 
age, breed, and dietary fiber on bacterial diversity in fecal samples from dogs using 
DGGE profiles, reporting that individual dogs have a stable, unique fecal flora (88). 
Also individually unique fecal flora have been observed in piglets living in the same 
environment and fed the same diet (89). These differences between individuals have 
been attributed to hitherto unknown host specific factors (111). In a recent study it has 
been reported that monozygotic twins have significantly higher similarity of fecal DGGE 
banding patterns than unrelated individuals, suggesting the host’s genotype may have an 
influence on the intestinal microflora (111).  
The canine intestinal microflora has almost exclusively been evaluated by 
traditional bacterial culture techniques (6, 10, 17). It has been reported that the normal 
canine duodenal microflora harbors a total bacterial count below 105 colony forming 
units per ml of duodenal juice (cfu/ml) (77). Higher duodenal bacterial counts were 
considered to contribute to intestinal disease and lead to a clinical syndrome called small 
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intestinal bacterial overgrowth (SIBO) (77). Significantly higher counts, however, have 
subsequently been documented in dogs with no signs of intestinal disease (41), leading 
to controversy over the true quantitative composition of the healthy canine duodenal 
microflora. The jejunal microflora has been reported to be quantitatively similar to the 
duodenum (6), whereas the ileal microflora increases in absolute bacterial counts to 
approximately 107 cfu/ml (6, 10, 17). The number of bacteria in the colon increases to a 
total bacterial count of approximately 109 to 1011 cfu/ml (6, 17). Very little is known 
about the qualitative variation in intestinal microflora between differing compartments 
within individual dogs. To our knowledge no study has evaluated differences between 
differing compartments of the canine intestinal tract using a molecular fingerprinting 
technique. In the study reported here we observed a remarkable variation in similarity of 
banding patterns between differing intestinal compartments within individual dogs. 
There was a gradual increase in band numbers down the length of the gut. Bacterial 
diversity indices were significantly higher in the large intestine than in the proximal 
small intestine. Bacterial diversity indices take into account the relative abundance of 
each individual species within a given community and, thus, provide information about 
the dominance of single species within a community or equal abundance of all species 
within a community, respectively. The more species that are present and the more evenly 
the total population is distributed between the species present, the more diverse the 
bacterial community. A highly diverse microflora is hypothesized to have more 
interactions within the community (73) and may be more stable and, therefore, more 
resistant to environmental changes (2). For example, a reduction in bacterial diversity 
has been found in the colonic microflora in humans with active inflammatory bowel 
disease, warranting bacterial diversity studies in dogs with intestinal disease (67). 
Several confounding factors of a molecular fingerprinting approach as described in this 
study, that may cause an over- or underestimation of bacterial diversity, need to be 
acknowledged. It has been suggested that DGGE bands represent the predominant 
bacterial species found in a microbial community (64), however PCR-DGGE analysis 
may exhibit bias by preferential amplification of bacterial species with DNA sequences 
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that show higher affinity for the universal primers compared to other bacterial species. 
The universal primers used in this study are commonly used in PCR-DGGE analysis 
from intestinal samples (102, 112). At higher cycle numbers PCR may exhibit bias, 
targeting only predominant species in the sample. For these reasons, PCR cycles should 
be kept to a minimum. In this study at least 29 cycles were needed to yield sufficient 
PCR product for DGGE analysis from samples obtained from the proximal small 
intestine. DGGE may also have limited resolving power, as PCR amplicons with closely 
related sequences may co-migrate and denature at the same time (64). Thus, bands on 
DGGE may be comprised of several amplicons, further underestimating bacterial 
diversity. Also, different strains of the same bacterial species may have resolvable 
differences in the V6-V8 region, yielding multiple bands. Despite this limitations, 
molecular fingerprint techniques have been proven to be powerful tools to illustrate the 
genetic diversity in a complex microbial community (49, 90). 
Individual dogs appear to possess unique individual bacterial communities in 
their large intestines. The colonic and rectal banding patterns obtained from the same 
dog tended to be more similar than the banding patterns from other dogs. This would 
suggest that each individual has a specific microflora in the large intestine, rather than 
the presence of a characteristic colonic or rectal microflora in dogs. While a similar trend 
was observed in the proximal small intestine, there was considerably more overlap 
between individual samples. This may be due to the lower bacterial diversity found in 
the proximal small intestinal microflora. In contrast, the microflora in the ileum was 
highly variable. In a subset of dogs the ileal microflora showed higher similarity with the 
proximal small intestine, while in another subset of dogs it showed higher similarity with 
the large intestine. This is surprising as the ileocolic valve is believed to be a natural 
barrier between the small and large intestine in dogs (31). This barrier, together with 
intestinal motility, is believed to prevent retrograde translocation of bacteria from the 
large into the small intestine. Dysfunction of the ileocolic valve has been suggested as a 
possible cause of intestinal disease, such as small intestinal bacterial overgrowth (SIBO) 
(31, 45). At this point it remains speculative that the variation in bacterial microflora in 
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the ileum between different dogs is caused by dysfunction in the ileocolic valve, and if 
so, whether this has any clinical significance. Clearly, further studies evaluating changes 
in the ileal microflora in a large group of dogs with intestinal disease are warranted.   
Our results are in agreement with a suggested qualitative variation in the canine 
intestinal microflora between compartments using bacterial culture (17). Few previous 
studies have examined this variation in the intestinal microflora in other species using 
molecular fingerprinting techniques (90, 102, 114).  For example, in humans it has been 
shown that the colonic microflora differs from the rectal microflora (114). In chickens 
and pigs, similar to the results in our study, neighboring compartments showed 
significantly higher similarity values than non-neighboring compartments (90, 102). 
These studies, together with data presented here, suggest that unknown, host-related 
factors, contribute to the development of a unique microflora in an individual, and that 
differing compartments of the intestinal tract should be seen as unique ecosystems (89, 
112). Differences in nutrient composition and concentration, differences in pH, and host 
secretions between various compartments of the intestine may contribute to this effect 
(88). Based on those findings, assessment of a duodenal or a fecal sample may not yield 
accurate information about the diversity of the microflora in other intestinal 
compartments.  
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CHAPTER IV 
ASSESSMENT OF THE CANINE INTESTINAL MICROFLORA BY 
COMPARATIVE 16S rDNA ANALYSIS 
OVERVIEW 
The normal intestinal bacterial flora in dogs has not been well defined. Previous 
studies have focused on identification and enumeration of bacterial species by direct 
culture of intestinal contents. However, recently, it has been recognized that the majority 
of microbial species cannot be identified using standard culture techniques. Reasons for 
this inability to culture many bacterial species include non-viable or stressed 
microorganisms, obligate requirements for coexisting flora or host-derived products, bias 
due to selectivity of culture media, and a lack of knowledge regarding essential nutrients 
for some bacterial species. Thus, a culture-dependent approach may underestimate the 
bacterial diversity of complex microbial communities such as those found in the 
intestinal tract. The aim of this study was to describe the intestinal microflora in healthy 
dogs by direct sequence analysis of the 16S ribosomal DNA (16S rDNA; gene encoding 
16S ribosomal RNA). Six healthy dogs, euthanatized for an unrelated study, were used. 
Immediately after euthanasia intestinal content was collected from the duodenum, 
jejunum, ileum, and colon. Bacterial DNA was purified by phenol:chloroform:iso-
amylalcohol extraction, and the 16S rDNA was amplified with universal bacterial 
primers at low PCR cycle numbers. Amplicons were ligated into linearized cloning 
vectors and chemically competent Escherichia coli organisms were transformed. 
Colonies were randomly selected, the plasmid DNA purified, and the 16S rDNA insert 
identified by bidirectional automated cycle sequencing. All non-redundant sequences 
were tested for possible chimeric structures and putative chimeras were excluded from 
further analysis. The cloned sequences were compared to existing 16S rDNA sequences 
in GenBank and the Ribosomal Database Project (RDP). From a total of 864 clones 
analyzed, 106 non-redundant bacterial 16S rDNA sequences were identified, reaching 
coverage of 87.4%. Forty two (40%) of these sequences showed less than 98% sequence 
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similarity to 16S rDNA sequences listed in GenBank and RDP, and may represent as of 
yet uncharacterized bacterial species. Four major phylogenetic lineages were identified, 
with the majority of 16S rDNA sequences belonging to the Clostridium, Bacteroides, 
Lactobacillus, Enterobacteriaceae and Fusobacterium groups. These data indicate that 
the canine intestinal microflora is very complex, and that the molecular approach 
described in this study can facilitate identification of bacterial species in the canine 
intestinal tract that have not previously been characterized. The clinical significance of 
the diverse intestinal microflora in dogs, and alterations in bacterial diversity that may 
occur with gastrointestinal disease, need to be further investigated. 
INTRODUCTION 
The normal canine intestinal microflora is not well characterized. Previous 
studies aiming to characterize the intestinal bacterial flora in dogs have focused on the 
identification and enumeration of bacterial species through cultivation of intestinal 
content (5, 6, 10, 17, 78, 106). Bacterial culture, however, has limitations for assessing 
bacterial diversity in the gut. Samples of intestinal fluid must be processed immediately 
in order to preserve both aerobic and anaerobic species. Thus, an on-site microbiology 
laboratory is required in order to obtain a reliable assessment of bacterial species present 
as well as bacterial counts when culturing intestinal content. The intestinal tract harbors 
many anaerobic bacteria, which are prone to damage during handling of samples. 
Identification of bacteria is based on phenotypic identification systems. This may lead to 
limitations in accurately characterizing all microorganisms in a given sample. It is also 
increasingly recognized that the majority of microbial species present in biological 
samples escape identification when standard culture techniques are used alone (1, 9, 48, 
49, 70, 96). Studies using a molecular biological approach, e.g. based on identification of 
16S ribosomal RNA (rRNA) or 16S ribosomal DNA (DNA encoding the16S rRNA), 
have identified a greater number of bacterial species when compared to standard culture 
techniques, indicating that only a small proportion of bacterial species are cultivable 
using standard bacterial culture techniques (37, 70, 96). Based on sequence analysis of 
PCR products new bacterial species, not previously identified by cultivation have been 
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demonstrated in fecal samples of humans and in the gastrointestinal tract of pigs (48, 
49).  
It has been estimated that the human gastrointestinal tract harbors 300-500 
different bacterial species and that 60 to 80% of these bacterial species have not yet been 
cultivated (48, 49). Reasons for this inability to culture many bacterial species include 
non-viable or stressed microorganisms, obligate requirements for coexisting flora or 
host-derived products, bias due to selectivity of culture media, and our lack of 
knowledge regarding essential nutrients for some bacterial species (15).  Based on these 
studies, it is very likely that a culture-dependent approach underestimates the bacterial 
diversity found in the intestine of dogs, and an approach based on molecular methods 
may identify greater bacterial diversity in the intestinal tract of the domestic dog than 
previously reported.  The aim of this study was to define the bacterial microflora in a 
group of healthy dogs by comparative 16S rDNA analysis.  
MATERIALS AND METHODS 
Sample material. Six healthy dogs, euthanatized for an unrelated study were 
used. No dog received any treatment (e.g., antibiotic therapy) that would be expected to 
have an impact on the composition of the intestinal microflora. Immediately after 
euthanasia intestinal content was collected from the duodenum, jejunum, ileum, and 
colon as described above.  
Extraction of DNA and 16S rDNA amplification. Genomic DNA was 
extracted from intestinal samples using a bead beating method followed by 
phenol:chloroform:iso-amylalcohol extraction as described previously (98). The 16S 
rDNA was amplified using primers Bact-0008F (5’ AGAGTTTGATCMTGGCTCAG 
3’) and Univ-1492R (5’ GGTTACCTTGTTACGACTT 3’) (49). Both primers were 
purchased from Gene Technologies Lab, College Station, Tex. DNA was amplified 
using the following reaction conditions: 20 mM Tris-HCl (pH 8.8), 2 mM MgSO4, 10 
mM KCl, 10 mM (NH4)2SO4, 0.1% Triton® X-100, 0.1 mg/ml bovine serum albumin, 
150 µM deoxynucleoside triphosphate, 1 mM MgCl2, 0.25 µM of each primer, 2.5 U Pfu 
DNA Polymerase (proofreading capacity) with exonuclease activity (Strategene, La 
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Jolla, Calif.), and 2 µl DNA template (approximately 100 ng of DNA) in a 50µl reaction 
volume. The samples were amplified in a thermocycler (Mastercycler Gradient, 
Eppendorf AG, Hamburg, Germany) using the following PCR protocol: an initial 
denaturation step at 94ºC for 3 min 15 sec; 15 cycles (denaturation at 94ºC for 45 sec, 
annealing at 54ºC for 45 sec, extension at 72ºC for 3 min 30 sec), and a final elongation 
step at 72ºC for 30 min. For samples that were obtained from the colon and ileum 5 
independent PCR reactions were performed, for samples that were obtained from the 
duodenum and jejunum 10 independent PCR reactions were performed. PCR products 
belonging to the same sample were pooled and concentrated using the QIAquick® PCR 
Purification Kit (Qiagen, Valencia, Calif.) following the manufacturer’s instructions. 
The purity and correct size of resulting PCR amplicons (approx. 1,450 bp) were assessed 
on 1.2% agarose electrophoresis gels, stained with ethidium bromide (staining for 15 
min and destaining in H2O for 60 min), and visualized under UV light.   
Cloning of 16S rDNA amplicons. Blunt end PCR products were ligated into 
linearized pCR-Blunt vectors (pCR®4Blunt-TOPO, Invitrogen, Carlsbad, Calif.) as 
specified by the manufacturer. Competent One Shot TOP10 Escherichia Coli organisms 
(Invitrogen) were transformed with ligation products by heat shock following the 
manufacturer’s instructions. Recombinant organisms were grown on Luria-Bertani 
medium with ampicillin (50 µg ml-1) at 37°C overnight. The pCR®4Blunt vector allows 
direct selection of recombinant cells via disruption of the lethal E. coli gene ccdB. Up to 
96 colonies per sample were picked randomly and transferred to 1.5 ml Luria-Bertani 
broth and grown at 37°C for 24 hours in 2 ml well 96-well blocks (Perfectprep® BAC 
96, Eppendorf) sealed with AirPore film (Eppendorf).  
Plasmid extraction and sequencing of 16S rDNA. Plasmid extraction was 
performed in a 96-well format using the Perfectprep® BAC 96 plasmid purification kit 
(Eppendorf) and a single vacuum manifold (Eppendorf) following the manufacturer’s 
instructions. Plasmid DNA was eluted with 50 µl of deionized water and the products 
were stored at -80°C until further use. The 16S rDNA inserts were analyzed by cycle 
sequencing using the ABI PRISM BigDye Terminator Cycle Sequencing Kit (Applied 
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Biosystems, Perkin-Elmer Corporation, Foster City, Calif.) and products were analyzed 
with an automated sequence analyzer (ABI PRISM 377 DNA Sequencer, Applied 
Biosystems). For provisional grouping of clones all clones were re-amplified from the 
5’-terminal of the 16S rDNA using a single primer (Bact-8F; 5’ 
AGAGTTTGATCMTGGCTCAG 3’). Obtained sequences with at least 98% similarity 
to each other were placed in groups using the software program FastGroup (82). One 
representative of each group was subjected to near-full-length bidirectional sequencing 
of both strands from positions 27 to 1492 of the 16S rDNA (E. Coli numbering) using 
the following primers: Bact-683R (5’ GCATTTCACCGCTACAC 3’), Bact-968F (5’ 
GAACGCGAAGAACCTTAC 3’), Bact-1054R (5’ ACGAGCTGACGACAGCCATG 
3’), and Univ-1492R (5’ GGTTACCTTGTTACGACTT 3’). 
Sequence analysis. All near-full-length sequences were edited to exclude the 
PCR primer binding sites and tested for possible chimeric artifacts using the Check-
_Chimera program and the Bellerophon software (36), both available through the 
Ribosomal Database Project (RDP). Putative chimeras were excluded from further 
analysis.   
All newly obtained near-full-length sequences were compared to existing 
sequences in RDP (release version 9.26; approximately 120,000 16S rRNA sequences) 
and the closest neighbor for each sequence was downloaded. Sequences from both, the 
intestinal clone library and public databases, were aligned with the CLUSTAL_W 
program. The resulting alignment was inspected and manually adjusted using the 
alignment editor in the BioEdit software package. Phylogenetic trees were inferred and 
drawn based on the neighbor-joining algorithm using the TREECON software package 
(version 1.3b) and the Jukes-Cantor model for inferring evolutionary distances (101). 
The stability of branches was assessed by the bootstrap method (100 replicates) by using 
the algorithms available in the TREECON package. An Operational Taxonomic Unit 
(OTU) was defined as a group of sequences with less than 2% sequence divergence 
(98% similarity) to each other. The coverage of the clone library (i.e., the probability 
that any additional analyzed clone is different from any previously analyzed clone) was 
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calculated according to Good (28) using the formula [1-(n/N)] x 100, where n is the 
number of molecular species represented by one clone and N is the total number of 
sequences. Diversity of the clone library was evaluated by rarefaction analysis (38). 
Rarefaction curves were produced by using the software program aRarefactWin 
(available at http://www.uga.edu/~strata/software).  
Nucleotide sequence accession numbers. Obtained near-full-length 16S rDNA 
sequences have been deposited in the GenBank database with accession numbers 
DQ113666 to DQ113771. 
RESULTS  
Phylogenetic analysis. A total of 988 clones were randomly selected from all 
samples. The cloning efficiency was 87.4% and a total of 864 clones contained an insert 
that could be sequenced. The partial sequence at the 5’ end of the 16S rDNA comprising 
the variable region V1 to V3 of the 16S rDNA gene was used for provisional grouping 
of sequences based on a 98% similarity criterion. One representative from each of the 
provisional groups was subjected to near-full-length sequencing yielding 124 16S rDNA 
sequences. Eighteen (14.5%) of these near-full-length sequences were identified as 
possible chimeras and were, together with the clones of the group they represented, 
excluded from further analysis. A total of 106 non-redundant near-full-length 16S rDNA 
sequences, representing a total of 711 clones, were used for subsequent phylogenetic 
analysis representing a coverage of 85.1% for the entire clone library (i.e., the 
probability of the next clone to represent a yet undiscovered OTU was 14.9%). The 
calculated rarefaction curve approached a horizontal line, indicating that the diversity of 
the OTUs was almost covered in the clone library (Fig. 8).  
Forty two (40%) of the obtained near-full-length sequences showed less than 
98% sequence similarity to existing 16S rDNA sequences in the GenBank and RDP 
databases, and may represent as yet uncharacterized bacterial species. The results of the 
phylogenetic positioning of the clones are shown in figure 9 and table 5.  Four major 
phylogenetic lineages were identified: the Firmicutes (47.7%), Bacteroidetes (12.4%), 
Proteobacteria (23.0%), and Fusobacteria (16.6%).  
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Flexibacter-Cytophaga-Bacteroides group. A total of 88 clones were affiliated 
with the class Bacteroides representing 13 individual phylotypes. Of these 38 clones 
representing 8 phylotypes belonged to the Bacteroides fragilis subgroup. Fifty clones 
representing 5 phylotypes fell into the Prevotella subgroup.  
Fusobacterium and relatives. A total of 118 clones representing 9 phylotypes 
belonging to the class Fusobacteria were observed. The genus Fusobacterium was the 
most predominant group within this class with 97 clones comprising 8 individual OTUs. 
One OTU observed in the jejunum, ileum, and colon, which was represented by 36 
clones, showed 96% similarity to Fusobacterium varium X55413. One OTU from the 
jejunum represented by 9 clones showed 99% similarity with Clostridium rectum. Two 
jejunal clones showed 98% similarity with Fusobacterium necrogenes. The 
Cetobacterium subgroup and Fusobacterium perfoetens were represented by 1 and 2 
OTUs, respectively. 
Bacillus-Lactobacillus-Streptococcus subdivision. Eighty-one clones 
representing 15 individual phylotypes were affiliated with the order Lactobacillales. The 
genus Lactobacillus was the largest subgroup with 41 clones representing 6 individual 
phylotypes. Several clones from the duodenum, jejunum, and colon showed more than 
98% similarity with Lactobacillus reuteri, Lactobacillus murinus, and Lactobacillus 
johnsonii, respectively. One OTU observed in the jejunum showed 96% similarity with 
Lactobacillus aviarius.  
Twenty-five clones representing 5 phylotypes were affiliated with the genus 
Streptococcaceae.  One OTU observed in the jejunum, ileum, and colon showed 99% 
similarity with Streptococcus lutetiensis. One OTU in the duodenum showed 99% 
similarity with Streptococcus alactolyticus and one OTU from the jejunum showed 99% 
similarity with Streptococcus suis. Two OTUs in the duodenum and jejunum showed 
95% similarity with Streptococcus agalactiae. 
One OTU showed 99% with Enterococcus cecorum Y18355. Two OTUs were 
affiliated with the Abiotrophia group.  
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Clostridium and relatives. A total of 203 clones were affiliated with the class 
Clostridia representing 34 different phylotypes. The majority of observed OTUs were 
affiliated with the Clostridium leptum subgroup and Clostridium barati subgroup. 
Several clones showed more than 98% similarity to Clostridium perfringens and were 
observed in the duodenum, ileum, and colon.  
Proteobacteria. A total of 164 clones representing 25 OTUs were affiliated with 
the phylum Proteobacteria. The class Gammaproteobacteria was represented by 138 
clones representing 22 OTUs. Within this class the family Enterobacteriaceae was the 
predominant subgroup with 126 clones representing 18 individual OTUs. The genus 
Escherichia was the most common representative with 85 clones, followed by the genus 
Klebsiella, which was represented by 20 clones.  
Eubacterium and relatives. Twenty-five clones representing 8 individual OTUs 
were affiliated with the Clostridium coccoides subgroup. A total of 117 clones 
representing 12 OTUs were affiliated with the Clostridium lituseburense subgroup. One 
OTU in the jejunum showed 99% similarity to Clostridium hiranonis, a bacterial species 
that displays bile acid 7-alpha-dehydroxylating activity. One OTU in the jejunum 
showed 99% similarity with Clostridium glycolicum. Finally, one OTU in the jejunum 
showed 93% similarity with Clostridium propionicum. 
Spatial differences within the canine intestinal tract. The majority of observed 
16S rDNA clones were affiliated with the bacterial orders of Clostridiales, 
Enterobacteriales, Lactobacillales, Fusobacteriales, and Bacteroidales. A spatial 
difference of these bacterial groups within different intestinal compartments was 
observed (Fig. 10). Table 6 summarizes the percentage of observed 16S rDNA clones 
belonging to different phylogenetic lineages in the different compartments of the canine 
intestinal tract.   
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FIG 8. Rarefaction curve for 16S rDNA clones. The observed number of individual 
OTUs is plotted against the number of analyzed clones. The rarefaction curve 
approaches a horizontal line indicating that the diversity of the clone library is almost 
covered. The dotted lines represent the 95% confidence interval for the rarefaction 
curve. 
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FIG 9—Next page. Dendrogram showing the phylogenetic affiliation of OTUs isolated from the 
canine GI tract. The bar represents 2% sequence divergence. Near-full-length 16S rDNA 
sequences were aligned to their closest neighbor in the RDP database. The tree was inferred 
based on the neighbor-joining algorithm. Bootstrap values shown at the branches are based on 
100 replicates. For each OTU the numbers in parenthesis indicate the number of observed clones 
in different intestinal compartments. (Duo=duodenum, Jej=jejunum, Ile=Ileum, Col=colon). 
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Clostridium sordellii M59105
Clostridium bartlettii AY438672
J5-32 (Duo 5, Jej 2, Ile 2)
Clostridium botulinum X73442
I8-63 (Duo 5, Jej 15, Ile 6, Col 2)
J1-33 (Jej 4)
Uncultured bacterium AF371691
D1-39 (Duo 2)
J1-13 (Duo 5, Jej 4, Col 2)
D1-03 (Duo 5)
Clostridium baratii AY341243
Eubacterium contortum L34615
C1-30 (Col 1)
D1-17 (Duo 2)
D5-90 (Duo 2, Jej 2)
C5-04 (Duo 4, Col 2)
Clostridium celatum X77844
J2-71 (Jej 2)
Ruminococcus gnavus L76597
D5-48 (Duo 2, Ile 2)
Ruminococcus luti AJ133124
Clostridium leptum AJ305238
uncultured bacterium AF371689
C1-02 (Duo 3, Col 2)
Uncultured bacterium AJ306761
Uncultured rumen bacterium AB185550
J5-14 (Duo 5, Jej 37, Ile 2)
Clostridium lituseburense M59107
I2-26 (Ile 3)
J5-58 (Duo 3, Jej 2)
I2-08 (Ile 4)
I5-47 (Ile 3)
C5-09 (Duo 4, Ile 2, Col 2)
Clostridium glycolicum AY244773
I2-45 (Ile 2)
Clostridium hiranonis AB023970
J2-51 (Jej 3)
D1-26 (Duo 2)
Clostridium propionicum X77841
Clostridiaceae bacterium AB078860
D5-67 (Duo 2)
Uncultured bacterium AJ315487
C5-15 (Col 3)
D1-19 (Duo 2)
C5-01 (Duo 2, Col 6)
Coprococcus catus AB038359
C2-38 (Col 2)
Ruminococcus obeum AY169419
C5-55 (Col 2)
Clostridium coccoides M59090
Ruminococcus productus AB196512
Candidatus Arthromitus sp. SFB-trout AY007720
D1-79 (Duo 3)
Clostridium disporicum Y18176
D1-45 (Duo 2)
Clostridium perfringens BA000016
I8-10 (Ile 9)
Clostridium thermocellum L09173
Clostridium thermolacticum X72870
Faecalibacterium prausnitzii AJ270469
C2-02 (Col 6)
Phascolarctobacterium faecium X72867
C2-26 (Col 6)
uncultured bacterium AF371703
Allisonella histaminiformans AF548373
C8-17 (Col 2)
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C5-71 (Col 2)
D5-04 (Duo 4)
Fusobacterium necrogenes X55408
Allobaculum stercoricanis AJ417075
D5-68 (Duo 3)
J2-93 (Jej 2)
J2-96 (Jej 9)
D5-53 (Duo 3)
J2-14 (Jej 2)
Eubacterium cylindroides AB018186
Lactobacillus murinus AY324630
J2-29 (Jej 2)
Streptococcus agalactiae X59032
J1-29 (Duo 2, Jej 3)
Clostridium ramosum M23731
Abiotrophia defectiva D50541
J2-13 (Jej 2)
C5-72 (Col 3)
J2-06 (Jej 2)
C5-42 (Duo 23, Jej 3, Col 4)
Uncultured bacterium clone AF371512
Eubacterium biforme M59230
Catenibacterium mitsuokai AB030221
C1-23 (Col 2)
Gemella palaticanis Y17280
J5-76 (Duo 2, Jej 3)
Turicibacter sanguinis AF349724
C5-70 (Jej 2, Col 3)
Streptococcus lutetiensis AF429763
C5-24 (Jej 2, Ile 2, Col 3)
Streptococcus alactolyticus AF201899
D5-02 (Duo 4)
Streptococcus suis AF009497
J5-01 (Jej 2)
J5-28 (Jej 2)
J1-46 (Duo 2, Jej 8)
Granulicatella adiacens AJ312375
Abiotrophia para-adiacens AB022027
Enterococcus cecorum Y18355
C2-39 (Col 2)
J1-18 (Jej 2)
D5-23 (Duo 4, Jej 2)
Lactobacillus reuteri AY735406
C5-95 (Duo 2, Col 2)
Lactobacillus johnsonii AE017201
D5-06 (Duo 13, Col 8)
Lactobacillus aviarius AB001836
J2-54 (Jej 2)
Lactobacillus animalis AY522567
D5-91 (Duo 4, Col 4)
Fusobacterium perfoetens M58684
I8-40 (Jej 5, Ile 18)
Cetobacterium somerae AJ438155
J2-01 (Jej 21)
Fusobacterium varium X55413
C5-19 (Jej 2, Ile 19, Col 15)
I8-13 (Ile 1)
C2-03 (Duo 2, Jej 3, Ile 6, Col 12)
Clostridium rectum X77850
Fusobacterium mortiferum M58680
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Bacteroides putredinis L16497
J5-06 (Jej 2)
Uncultured bacterium clone AY916231
Achromobacter xylosoxidans AY244787
Actinobacillus rossii AY465362
J5-64 (Jej 4)
J5-04 (Jej 14)
J2-15 (Jej 3)
C5-17 (Ile 2, Col 2)
Bacteroides caccae X83951
Escherichia coli J01695
uncultured bacterium J308395
Shigella flexneri X96963
Raoultella planticola Y17659
Uncultured rumen bacterium AB034021
D1-44 (Duo 7)
Shigella sonnei X96964
Bacteroides splanchnicus L16496
Lautropia sp. oral clone AP009 AY005030
D5-43 (Duo 2)
I8-21 (Ile 8, Col 4)
Pasteurella trehalosi U57074
C2-34 (Duo 2, Col 2)
J5-12 (Jej 23)
I2-01 (Ile 12)
I8-91 (Ile 6, Col 2)
D1-05 (Duo 4)
uncultured bacterium human colon AJ408960
C5-10 (Duo 4, Jej 2, Col 12)
Ralstonia pickettii Y268179
J2-77 (Jej 2)
I8-33 (Duo 2, Ile3)
D5-79 (Duo 2)
Actinobacillus equuli AF381186
Actinobacillus capsulatus AF145255
Bisgaard Taxon 16 AF224294
I2-02 (Ile 2)
Aeromonas hydrophila sp dhakensis AJ50876
D1-82 (Duo 3)
Pantoea sp AF227846
D1-74 (Duo 2)
Klebsiella pneumoniae Y17657
D1-78 (Duo 8)
Enterobacter hormaechei sp steigerwaltii
D1-52 (Duo 2)
D1-67 (Duo 3)
D1-50 (Duo 12)
Shigella boydii AY696666
I2-35 (Ile 3)
I8-60 (Duo 6, Ile 4, Col 2)
J1-15 (Jej 3)
I8-66 (Duo 4, Ile 3)
I8-51 (Jej 2, Ile 4)
uncultured bacterium AF371848
J1-37 (Jej 2)
uncultured epsilon proteobacterium AF44570
uncultured proteobacterium AF402974
Bacteroides merdae AY169416
Bacteroides distasonis M86695
uncultured bacterium adhufec AF15386
C5-79 (Jej 4, Ile 4, Col 18)
uncultured bacterium adhufec AF132282
C1-34 (Jej 2, Col 4)
I2-48 (Ile 3)
C2-12 (Col 2)
Prevotella sp. oral clone AY349402
Prevotellaceae bacterium AY207061
I8-18 (Ile 2)
I8-14 (Jej 2, Ile 5, Col 5)
Uncultured bacterium CR933222
C5-03 (Col 2)
Bacteroides vulgatus AB050111
C2-20 (Col 2)
Bacteroides stercoris X83953
Bacteroides thetaiotaomicron AY895200
Bacteroides fragilis X83942
Bacteroides uniformis AY349154
C5-34 (Jej 2, Ile 2, Col 2)
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B. Phylum Fusobacteria (9 OTUs; 118 clones) 
class Fusobacteria (9; 118)  
order Fusobacteriales  
family Incertae sedis   
genus Cetobacterium (1; 21)  
family Fusobacteriaceae  
genus Fusobacterium (8; 97) 
 
C. Phylum Bacteroidetes (13 OTUs; 88 clones) 
class Bacteroidetes (13; 88)  
order Bacteroidales  
family Bacteroidaceae  
genus Bacteroides (8; 38)  
family Prevotellaceae  
genus Prevotella (5; 50) 
 
D. Phylum Proteobacteria (25 OTUs; 164 clones)  
class Betaproteobacteria (3; 26)  
order Burkholderiales  
family Burkholderiaceae  
genus Ralstonia (1; 2)  
unclassified Burkholderiales (2; 24)  
class Gammaproteobacteria (22; 138)  
order Aeromonadales  
family Aeromonadaceae  
genus Aeromonas (1; 3)  
order Pasteurellales  
family Pasteurellaceae  
unclassified Pasteurellaceae (3; 9)  
order Enterobacteriales  
family Enterobacteriaceae  
genus Klebsiella (2; 20)  
genus Enterobacter (2; 4)  
genus Escherichia (11; 85)  
unclassified Enterobacteriaceae (3;17) 
 
E. Unclassified Bacteria (1 OTU) 
 
 
 
A. Phylum Firmicutes (58 OTUs; 339 clones) 
class Bacilli (17; 91)  
order Bacillales  
family Staphylococcaceae  
genus Gemella (1; 5)  
order Lactobacillales  
family Carnobacteriaceae  
genus Granulicatella (1; 5)  
 family Aerococcaceae  
genus Facklamia (1; 2)  
unclassified Aerococcaceae (1; 6)  
family Lactobacillaceae  
genus Lactobacillus (6; 41)  
family Streptococcaceae  
genus Streptococcus (5; 25)  
family Enterococcaceae  
genus Enterococcus (1; 2)  
unclassified Bacilli (1; 5)  
class Mollicutes (2; 32)  
order Incertae sedis  
family Erysipelotrichaceae  
genus Erysipelothrix (1; 2)  
 unclassified Mollicutes (1; 30) 
class Clostridia (34; 203)  
order Clostridiales  
family Peptostreptococcaceae  
genus Peptostreptococcus (1; 3)  
family Acidaminococcaceae  
genus Allisonella (1; 2)  
genus Phascolarctobacterium (1;6)  
family Lachnospiraceae  
genus Ruminococcus (2; 10)  
genus Anaerofilum (1; 6)  
unclassified Lachnospiraceae (4;10)  
family Clostridiaceae  
genus Dorea (1; 5)  
genus Clostridium (17; 151)  
unclassified Clostridiaceae (1; 3)  
unclassified Clostridiales (5; 13)  
unclassified Firmicutes (5; 13) 
 
 
TABLE 5. Phylogenetic classification of the 106 operative taxonomical units (OTUs) 
and respective number of clones obtained from the canine GI tract. Classification is 
based on the taxonomical hierarchy proposed in Bergey's Manual of Systematic 
Bacteriology (Ribosomal Database Project classifier).  
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Duodenum Jejunum Ileum Colon
Clostridiales 40.0% 38.8% 24.8% 26.1%
Lactobacillales 24.7% 12.6% 1.4% 13.4%
Fusobacteriales 3.3% 14.2% 32.6% 28.9%
Enterobacteriales 32.0% 27.3% 18.4% 1.4%
Bacteroidales 0.0% 7.1% 22.7% 30.3%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG 10. Percentage of 16S rDNA clones belonging to the major phylogenetic lineages in 
the different compartments of the canine intestinal tract.    
 
 
 
TABLE 6. Percentages of 16S rDNA clones belonging to the major phylogenetic 
lineages in different compartments of the canine intestinal tract.     
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DISCUSSION 
To date bacterial culture techniques have been used for characterization of the 
canine intestinal microflora (6, 10, 17). However, recently it has been recognized that a 
majority of intestinal bacteria is not cultivable using standard bacterial culture 
techniques and molecular approaches based on the identification of the 16S rDNA have 
been successful in identifying many new bacterial species present in the intestine of 
various mammalian species (e.g., humans, pigs, and chickens) (9, 30, 33, 35, 47, 49, 70, 
80, 84, 85, 87, 96, 103, 113). However, these molecular studies have focused almost 
exclusively on the microflora present in the colon or in fecal samples. Only few studies, 
performed in humans and pigs, have attempted to characterize the microflora in the 
ileum (49, 104). No published studies are available that characterize the intestinal 
microflora in the proximal small intestine (i.e., duodenum and jejunum) or along the 
entire intestinal tract of any mammalian species. A previous study using molecular 
fingerprinting techniques in healthy dogs has revealed marked qualitative differences in 
molecular fingerprints between individual intestinal compartments, suggesting that each 
area of the intestine harbors an unique ecosystem (98). Therefore, accurate 
characterization of the microflora in all intestinal compartments is warranted. The 
molecular approach, as described in this study, has revealed the presence of a complex 
intestinal microflora in the canine intestine. Our findings confirm the presence of several 
bacterial species that have been recently identified in fecal samples of other mammalian 
species. For example, one OTU observed in the canine jejunum shared 98% similarity 
with Cetobacterium somerae, a gram-negative, microaerotolerant, non-spore-forming, 
rod-shaped bacterium belonging to the class Fusobacteriales that has recently been 
isolated from the feces of children (20). Another OTU observed in the colon of one dog 
shared 99% similarity with Allisonella histaminiformis, a histamine producing bacterium 
belonging to the family Acidaminococcaceae (class Clostridiales) that has previously 
been identified in bovine and equine fecal samples (24). One OTU found in the 
duodenum of a dog shared 97% similarity with the gram-positive bacterium Candidatus 
Arthromitus, a long segmented filamentous bacterium (SFB). To date SFB have not been 
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successfully cultured but have been identified in the intestine of mice, rats, and chickens 
using molecular methods (92). 
It has been estimated that the mammalian intestinal microflora comprises 
approximately 300-400 different bacterial species (49). In this present study a total of 
106 individual near-full-length sequences have been identified in the intestine of six 
healthy dogs. Of these, 42 near-full-length 16S rDNA sequences showed less than 98% 
similarity to available 16S rDNA sequences in public databases, suggesting that these 
sequences represent previously uncharacterized bacteria. However, due to some 
limitations of bacterial identification based on direct sequencing of the 16S rDNA, it is 
likely that these findings still underestimate the total diversity of the canine intestinal 
microflora. Since a molecular approach using universal primers targets the predominant 
bacterial groups in the intestine (63), bacteria with low abundance might have escaped 
identification in this study. Further studies using group specific primers may lead to the 
identification of bacteria present in low numbers in the intestine. Currently, there is no 
consensus in the scientific literature about the degree of sequence divergence in the 16S 
rDNA that allows for clear discrimination between two bacterial species. Some closely 
related species may share a high similarity between their 16S rDNA sequences thus not 
allowing their discrimination on a species level. While, less than 97% similarity between 
16S rDNA sequences is generally an accepted cut-off for differentiation between 
different bacterial species (94), some bacterial species clearly belonging to different 
bacterial groups may exhibit more than 97% similarity of their 16S rDNA (21). A 98% 
similarity cut-off is commonly used if near-full-length 16S rDNA sequences are 
analyzed (33, 96).  
There was an obvious difference in the bacterial microflora between different 
intestinal compartments. While Proteobacteria (including Escherichia coli) were a 
substantial constituent of the duodenal microflora (32%), there was a low abundance of 
this phylum in the colon (1.4%). This low abundance in the colon is consistent with 
other studies where it has been shown that facultative anaerobic species represent only 
approximately 0.1% of bacteria in the strict anaerobic environment of the colon (96). 
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Anaerobic Bacteroides spp. and Fusobacterium spp. were only sporadically found in the 
proximal small intestine (i.e., duodenum and jejunum) but were substantial constituents 
of the microflora of the ileum and colon, respectively. Based on the relative abundance 
of 16S rDNA clones, bacteria belonging to the class Clostridiales were a substantial 
constituent of the canine intestinal microflora in all intestinal compartments and a total 
of 34 individual members of the class Clostridia could be identified.  
Members of the class Lactobacillales were present in high abundance in the 
duodenum, jejunum, and colon in all dogs. While Lactobacillus spp. were also observed 
in the ileum, they were present only as a minor fraction (1.4%) of all identified clones in 
the ileum. Similar to a study performed using bacterial culture on jejunal fluid in dogs 
Streptococcus alactolyticus, Lactobacillus murinus, and Lactobacillus reuteri were 
observed in  the proximal small intestine of dogs (75). Other prominent members of the 
Bacillus-Lactobacillus-Streptococcus subdivision were Lactobacillus johnsonii and 
Lactobacillus aviarius. In the present study no Bifidobacteria spp. were observed. 
Bifidobacteria spp. are part of the normal human intestinal microflora and are considered 
beneficial microorganisms. In dogs isolation of Bifidobacteria spp. has not been 
consistently reported. Based on bacterial culture up to 1010 colony forming units of 
Bifidobacteria spp. per ml intestinal juice (cfu/ml) have been reported in the large 
intestine of Beagle dogs (6, 17, 59). A lower abundance of Bifidobacteria spp. has also 
been reported in the proximal small intestine (6, 17, 59). However, other authors have 
not isolated Bifidobacteria spp. from the canine small intestine (18, 107). Also, a study 
characterizing the fecal microflora from a Labrador Retriever demonstrated that despite 
using Beerens agar, a medium specifically designed for the isolation of bifidobacteria, a 
mixture of various organisms other than Bifidobacteria spp. was isolated (30).  
In conclusion, a molecular approach as described in this study facilitated 
identification of several previously uncharacterized bacterial 16S rDNA sequences in the 
intestinal tract of healthy dogs. A molecular approach may further aid in the 
identification of uncharacterized bacteria in dogs with intestinal disease and warrants 
future studies about their role in dogs with gastrointestinal disease. 
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CHAPTER V 
DEVELOPMENT OF A 13C-GLYCOCHOLIC ACID BLOOD TEST FOR 
ASSESSMENT OF SMALL INTESTINAL METABOLIC ACTIVITY IN DOGS* 
OVERVIEW 
The objectives of this study were to establish optimal doses of 13C-glycocolic 
acid (GCA) for use in a 13C-glycocolic acid blood test (GCA) as a marker for small 
intestinal bacterial metabolic activity in dogs. Eight healthy dogs were enrolled in this 
study. Four doses of GCA, 0.5, 1, 2, and 4 mg/kg body weight, were evaluated. GCA 
was administered orally. Blood samples were collected at 0, 15, 30, 45, 60, 75, 90, 105, 
120, 135, 150, 165, 180, 210, 240, 270, 300, 330, 360, 390, 420, 450, and 480 min. 
Blood samples were immediately transferred into evacuated tubes containing 2 ml of 6 N 
hydrochloric acid. The percent dose/min of 13C administered as GCA (PCD) and 
cumulative PCD (CUMPCD) were determined by fractional mass spectrometry. No dog 
showed any clinically obvious side effects after oral administration of GCA.  Doses of 1 
and 2 mg/kg led to a significant increase in PCD and CUMPCD over time (p<0.001). 
The time-point for the peak PCD showed a high degree of variation between dogs and 
doses. The mean CUMPCD was significantly higher for the 1 mg/kg dose compared to 
the 2 and 4 mg/kg doses (p<0.05), suggesting saturation of the capacity of the intestinal 
microflora to deconjugate administered GCA. Administration of 1 mg/kg of 13C-
glycocholic acid led to an increase in CUMPCD over baseline in gas extracted from 
blood samples in all 8 healthy dogs and thus appears to be the best parameter to evaluate 
for future clinical studies.  
__________________          
*Reprinted with permission from Suchodolski J.S., Ruaux C.G., Steiner J.M., Fetz K., Berghoff N., 
and Williams D.A. 2005. Development of a 13C-glycocholic acid blood test for assessment of the small 
intestinal microflora in dogs. Can. J. Vet. Res. (in press) 
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INTRODUCTION 
It is generally accepted that some canine patients present with a chronic, 
relapsing diarrhea that is responsive to antibiotic therapy. This condition has been 
referred to as “Small Intestinal Bacterial Overgrowth” by many authors (52, 62), 
although this terminology remains controversial as there is little objective data regarding 
the normal bacterial flora of the canine small intestine. While quantitative aerobic and 
anaerobic bacterial culture of the duodenal juice is considered the gold-standard for 
diagnosis of small intestinal bacterial overgrowth, the technical difficulty of this 
procedure limits its routine use in clinical practice. Also, it has been recently recognized 
that the majority of microbial species present in biological samples escapes identification 
by use of standard culture techniques alone (49, 96). For example, it has been estimated 
that 60 to 80% of bacterial organisms present in the gastrointestinal tract of humans and 
pigs have not yet been identified (48, 49). There is a significant need for a diagnostic test 
that will accurately reflect the bacterial content of the small intestine in dogs. Ideally, 
such a test would be sensitive and specific, non-invasive, readily available to general 
practitioners, and not require complicated sample handling. 
14C- and the 13C-glycocholic acid breath tests have been used to diagnose small 
intestinal bacterial overgrowth in humans (71, 93). The 13C-glycocholic acid breath test 
is based on the deconjugation of the naturally occurring bile acid glycocholic acid by 
intestinal bacteria. 13C-glycocholic acid (GCA) is the glycine conjugate of cholic acid 
(Fig. 11). One carbon of the glycine residue is labeled with 13C, a stable carbon isotope, 
and thus can serve as a tracer. After oral administration, GCA reaches the small intestine 
where it enters the physiological bile acid pool and undergoes enterohepatic circulation. 
Bacteria present in the small intestine deconjugate the 13C-glycine portion from the core 
bile acid. The 13C-glycine is metabolized by intestinal bacteria and 13C is released. The 
13C freely diffuses into the blood stream where it may be transported in three different 
forms, dissolved in the plasma, bound to hemoglobin, and as bicarbonate. Eventually 
13CO2 is exhaled and can be quantified in breath (71). Alternatively, 13C can be measured 
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in blood samples (16, 61). Addition of 6 N HCl to a blood sample releases 13CO2, which 
can then be quantified by fractional mass spectrometry.  
The presence of increased bacterial numbers in the upper small intestine may 
lead to an increase in the proportion of the orally administered dose of 13C-glycocholic 
acid, which undergoes deconjugation. Thus, as has been observed in humans, an increase 
in small intestinal bacterial numbers may lead to an increase in the fraction of the 13CO2 
fraction of CO2 in the circulation in comparison to healthy individuals (71). The aim of 
this study was to establish an optimal dose of GCA for use in a GCA blood test as a 
potential marker for small intestinal bacterial biomass and metabolic activity in dogs. 
 
 
 
 
 
 
 
 
 
 
 
 
FIG 11. Principles of the 13C- glycocholic acid blood test. 
 
MATERIALS AND METHODS 
The protocol was approved by the University Laboratory Animal Care 
Committee at Texas A&M University. Eight healthy female Hound dogs (median age: 
3.0 years; range: 1 to 6.5 years) were enrolled in this study. Before the beginning of the 
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δ
13CSample (‰) = [(RSample/RPDB) - 1] x 1000  
where 
 RSample = 13C/12C = [(δ13CSample/1000) + 1] x RPDB 
study serum folate, cobalamin, unconjugated bile acids, and trypsin-like 
immunoreactivity concentrations were evaluated to screen for gastrointestinal disease.  
Four doses of 13C-glycocholic acid (Glycocholic acid-13C [glycyl-1-13C], CDN Isotopes, 
Point-Claire, Quebec, Canada), 0.5 mg/kg (body weight), 1 mg/kg, 2 mg/kg, and 4 
mg/kg body weight, were evaluated in a randomized study design. During each study 
period all dogs were given the same dose, with at least a 14-day rest period between 
individual study periods. Dogs were fed at 10 AM on the day prior to each study period. 
At 3 PM of that day, all food dishes and unconsumed food were removed from the dog 
runs. Venous access was established in each dog by insertion of a 12-inch-long, 18.5-
gauge, indwelling catheter (Venocath, Abbott Laboratories, Abbott Park, Illinois, USA) 
into a jugular vein. After collection of a 1 ml baseline blood sample, GCA dissolved in 
50 ml of deionized H2O was administered using a gastric feeding tube. Additional 1 ml 
blood samples were collected at 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 
210, 240, 270, 300, 330, 360, 390, 420, 450, and 480 min after GCA administration. 
Blood samples were immediately transferred into evacuated tubes (Vacutainer Sodium 
Lithium 10mL, Becton Dickinson, Franklin Lanes, New Jersey, USA) containing 2 ml of 
6 N hydrochloric acid.  
The 13CO2 released into the gas phase above the blood sample in each tube was 
determined by gas chromatograph isotope ratio mass spectrometry (Automated Breath 
13Carbon Analyzer, Europa Scientific Ltd., Crewe, United Kingdom) and expressed as a 
relative isotope ratio 13CO2:12CO2 (i.e. percentage 13CO2 in total CO2 above background 
13CO2 concentration in the environment) (13). This relative isotope ratio was then 
converted into an absolute ratio (RSample) by comparing the measured 13CO2:12CO2 of the 
sample with the absolute 13CO2:12CO2 ratio of the international calcium carbonate 
standard PDB (Pee Dee belemnite; PDB is a limestone fossil of Belemnitella americana 
from the Cretaceous Pee Dee formation in South Carolina) and calculated from the 
following equation (8):  
 
 
 69 
___________________________
13C expired (µmol/min)___________________________ 
{{[(amount of 13GCA given (mg) X 1000)/MW] X (atom%) X (# labeled atoms)} X 1000} 
CUMPCD = {[(PCDt + PCDt-1) X ∆t (min)]/2} + CUMPCDt-1 
The δ13CSample is the relative difference of the sample to PDB. PDB has, by 
international convention, an arbitrarily assigned δ13C value of 0‰, its absolute 13C:12C 
(RPDB) has been reported as 0.0112372 (8). A negative or positive δ13C indicates that the 
sample contains relatively less or more 13C than the PDB, respectively.  
The data was initially expressed as δ13CSample over baseline (DOB). The 13C 
expired (µmol/min) was calculated as DOB x 0.0112372 x CO2 produced. The CO2 
production was estimated using the following calculation: (RER x RQ)/4.8 L, where 
RER is the resting energy requirement (BW0.75 x 70) and RQ the respiratory quotient 
(estimated RQ for canine diets was 0.8). 
The percent dose/min of 13C administered as GCA (PCD) was calculated using 
the following formula:  
 
 
where MW is the molecular weight of the 13GCA. 
The cumulative PCD (CUMPCD) is the cumulative % of the dose recovered, and 
was calculated as:  
 
PCDs and CUMPCDs were compared for each one of the 4 individual doses using a 1-
way ANOVA followed by Tukey’s multiple comparison tests. The effect of the differing 
doses on PCDs and CUMPCDs over time was analyzed by a 2-way ANOVA.  
Coefficients of variation (CV% = (standard deviation/mean) X 100) were calculated for 
both PCD and CUMPCD values for each time point and for each dose. The mean %CVs 
for the 1 mg/kg and 2 mg/kg dose were compared using a student’s t-test. Data were 
analyzed using a statistical software package (GraphPad Prism 3.0, GraphPad Software 
Inc, San Diego, California, USA). 
RESULTS 
Prior to being enrolled into the study none of the dogs had any history of clinical 
signs or any changes in evaluated blood parameters that would be consistent with 
gastrointestinal disease.  
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None of the dogs showed any clinically obvious side effects after oral 
administration of GCA. Neither the 0.5 mg/kg nor the 4 mg/kg dose lead to a significant 
increase in PCD over time (p=0.083 and p=0.107, respectively), but both doses led to a 
significant increase in CUMPCD over time (p<0.0001 for both doses). Both the 1 and 2 
mg/kg doses led to significant increases in PCD (p<0.0001 and p=0.024, respectively) 
and CUMPCD over time (p<0.0001 for both doses; Fig. 12). The time-points for peak 
PCDs showed a high degree of variation between dogs and doses (Fig. 13). The mean 
CUMPCD was significantly higher for the 1 mg/kg dose than the other doses (p<0.05; 
Fig. 12). Administration of 1 mg/kg of GCA led to an increase in CUMPCD over 
baseline in gas extracted from blood samples in all 8 healthy dogs (Fig. 14), whereas 7/8 
dogs had an increase in CUMPCD over baseline after administration of 2 mg/kg GCA. 
There was no significant difference between the mean %CVs for CUMPCD between the 
1 mg/kg and 2 mg/kg dose (p=0.535).  
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FIG 12. Cumulative percent dose/min of 13C administered as 13C-glycocholic acid 
(CUMPCD). All 4 doses led to a significant increase of CUMPCD over time (p<0.001). 
The lower CUMPCD of the 0.5 mg/kg dose compared to the 1 mg/kg dose suggests lack 
of substrate for intestinal bacteria, while the lower CUMPCD of the 2 and 4 mg/kg dose 
suggests saturation of the deconjugation capacity of the small intestinal microflora.  
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FIG 13. The percent dose/min of 13C administered as GCA (PCD). The 1 and 2 mg/kg 
doses led to a significant increase in PCD. However, the time-point for the peak PCD 
showed a high degree of variation between dogs and doses. Therefore, determination of 
CUMPCD (Figure 2) is suggested for future clinical studies. 
 
 
 
 
 
 
 
 
 
 
 
 
FIG 14. Individual cumulative percent dose/min of 13C administered as 13C-glycocholic 
acid (CUMPCD) in 8 healthy dogs after administration of 1 mg/kg 13C-glycocholic acid. 
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DISCUSSION 
Previous studies have shown that bacterial deconjugation (i.e. the ability of 
bacteria to remove a glycine or taurine moiety) of bile acids, and the subsequent 
appearance of unconjugated bile acids in serum, can serve as an non-invasive marker for 
small intestinal bacterial metabolic activity in dogs (57). Sample preparation for 
measurement of serum unconjugated bile acids is technically challenging, time-
consuming and, therefore, relatively expensive. Also, it has been speculated that 
spurious elevations of serum unconjugated bile acid concentrations and hence a false 
positive diagnosis of small intestinal bacterial overgrowth may also be obtained through 
entry of small amounts of bile into the small intestine during the fasted state as a result 
of migrating motor complexes and spontaneous gall bladder contraction (76). The 13C-
glycocholic acid blood test (GCA) potentially combines the benefits of the measurement 
of a bacteria-specific metabolic activity with the minimally invasive nature of a blood 
test, and has a considerably lower technical difficulty in sample preparation than the 
unconjugated bile acids test.  As the compound being administered is not present in the 
normal bile acid pool, this test is potentially less dependant upon strict fasting and less 
susceptible to interference from migrating motor complexes and spontaneous gall 
bladder contraction. The carbon dioxide is easily extracted from a blood sample by the 
addition of hydrochloric acid, and no subsequent processing is necessary before 
measurement of the 13C-labeled carbon dioxide via fractional mass spectrometry. While 
the measurement of 13C in clinical samples necessitates the use of expensive equipment, 
i.e. an automated breath 13C analyzer, recent studies have shown that samples can be 
obtained easily in clinical settings and shipped to an appropriate laboratory which has 
the necessary equipment for analysis of samples (12). Also, recent studies have 
demonstrated that samples are stable for up to 3 weeks at room temperature, thus 
allowing storage and shipment to the laboratory (12).  
In this study we evaluated four different doses of GCA. After oral administration 
of up to 4 mg/kg of 13C-glycocholic acid no gross clinical evidence of adverse effects 
were observed during the course of the study, suggesting that the GCA test is safe in 
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healthy dogs. Safety of GCA needs to be further evaluated in dogs with gastrointestinal 
disease. 
 In this study only the 1 mg/kg and 2 mg/kg dose led to a significant increase in 
both PCD and CUMPCD over time. The lower CUMPCD of the 0.5 mg/kg dose 
compared to the 1 mg/kg dose suggests lack of substrate for intestinal bacteria. 
Increasing the GCA dose to 2 and 4 mg/kg led to a decrease in CUMPCD, suggesting 
saturation of the capacity of the intestinal microflora to deconjugate administered GCA. 
Determination of PCD and their summation (ie, cumulative PCD or CUMPCD) have 
been traditionally used in humans to measure bacterial metabolic mass (71). 
Determination of a peak PCD would be preferable compared to CUMPCD as fewer 
samples, i.e. a baseline sample and a sample taken at the time of the PCD peak, would be 
required. The peak PCD for the 1 mg/kg and 2 mg/kg dose showed a high degree of 
variation between individual dogs, preventing the selection of an optimal sampling time 
point for determination of PCD. This variation might be due to differences in intestinal 
motility or differences in composition of the intestinal microflora leading to different 
deconjugation kinetics, between individual dogs. The CUMPCD showed a lower degree 
of variation between dogs, suggesting that the CUMPCD would be a more reliable 
parameter than the PCD. Administration of 1 mg/kg of 13C-glycocholic acid led to an 
increase in CUMPCD over baseline in gas extracted from blood samples in all 8 healthy 
dogs and thus this dose appears to be the best parameter to evaluate for future clinical 
studies. However, while a 1mg/kg dose appears to be the best dose to use in healthy 
dogs, it may be necessary also to evaluate other higher doses in clinically ill dogs with 
suspected bacterial overgrowth or the lack of substrate effect as noted in the current 
study at the 0.5 mg/kg dose may be noted. Additional studies that evaluate the clinical 
utility of the GCA test in dogs with suspected small intestinal bacterial overgrowth are 
warranted.  
 75 
CHAPTER VI 
EFFECT OF ANTIBIOTIC THERAPY ON SERUM MARKERS FOR 
ASSESSMENT OF  
THE SMALL INTESTINAL MICROFLORA  
OVERVIEW 
The difficulties in culturing canine duodenal juice limit the ability of clinicians to 
assess the small intestinal microflora in dogs. Serum markers and dynamic tests for 
assessment of the small intestinal microflora have been described. These tests assess 
changes in bacterial metabolic mass (serum unconjugated cholic acid (SUCA) and 13C-
glycocholic acid blood test (13C-GCBT)), bacterial synthetic activity (serum folate 
concentration), and bacterial competition for dietary substrates (serum cobalamin 
concentration). The aim of this study was to determine the effect of antibiotic therapy 
with oral tylosin of these markers of small intestinal microflora. Ten healthy hound-cross 
laboratory dogs, all intact females, were selected from an in-house colony. Dogs were 
relocated into a special laboratory dog ward and acclimated for 1 month prior to starting 
the study. At day 0, following overnight withholding of food, indwelling jugular 
catheters were placed and baseline sera for determination of cobalamin, folate, and 
unconjugated cholic acid concentrations were collected. A 13C-GCBT was then carried 
out, using 1 mg/kg 13C-glycocholic acid mixed with an egg yolk and baked in a 
microwave for 1 minute. The dogs then received 25 mg/kg tylosin per os BID for 28 
days. On day 28, jugular catheters were once again placed, baseline sera were collected, 
and the 13C-GCBT was repeated. Serum concentrations of cobalamin, folate, and 
unconjugated cholic acids were determined also days 28 and 56. The cumulative 
percentage of the administered dose recovered (CUMPCD) was determined in blood 
samples by fractional mass spectrometry. Data were analyzed using repeated measures 
ANOVA, or a Friedman’s test if data were not normally distributed.  
Tylosin treatment was associated with significant changes in some of the serum 
markers for assessment of the intestinal microflora in these dogs. Serum cobalamin 
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concentrations showed no change after tylosin administration. Serum folate 
concentrations increased significantly after tylosin administration (p<0.001). Also, 
SUCA increased significantly after tylosin administration (p<0.01). Overall bacterial bile 
acid metabolism as assessed by the 13C-GCBT increased significantly (p<0.001) 
following tylosin administration. These data suggest that tylosin administration is 
associated with alterations in the canine small intestinal flora, reflected in alterations in 
serum markers and dynamic tests of the small intestinal microflora. Increased serum 
folate, SUCA, and CUMPCD in the 13C-GCBT suggest that, in the dogs described here, 
tylosin administration increased the biomass of organisms carrying out these metabolic 
functions. 
INTRODUCTION 
 Assessment of the numbers and types of bacteria in the small intestine of dogs is 
challenging, as obtaining a sample requires anesthesia and either endoscopic collection 
of duodenal juice or an invasive surgical procedure. This complicates both, research 
concerning the intestinal microflora and also the possibility of diagnosing disorders that 
involve the small intestinal microflora in dogs. We recently developed a 13C-glycocholic 
acid blood test (13C-GCBT) as a minimally invasive test for quantification of small 
intestinal bacterial biomass in dogs, and established optimal dose and sampling times. 
The principles behind 13C-GCBT are that after oral administration of 13C-labeled 
glycocholic acid (a naturally occurring bile acid), the glycocholic acid can be broken 
down by bacteria in the intestine, yielding 13CO2 that can be quantified in a blood sample 
(see Chapter V).  
 The hypotheses for this study were that antibiotic therapy with a broad spectrum 
antibiotic agent, tylosin, leads to a decrease in the number of bacteria present in the 
small intestine, that these changes can be subsequently assessed by the 13C-GCBT, and 
changes in commonly used minimally-invasive serum markers (i.e., serum cobalamin, 
serum folate, and serum unconjugated cholic acid concentrations) are altered by 
antibiotic therapy with tylosin. The antibiotic tylosin (Tylan®) was chosen because it is 
 77 
commonly recommended for treatment of intestinal disorders such as small intestinal 
bacterial overgrowth or antibiotic-responsive diarrhea in canine patients (105). 
MATERIALS AND METHODS 
Animals. This part of the project involved the use of research dogs and was 
approved by the University Laboratory Animal Care Committee at Texas A&M 
University (AUP #2004-117). Ten healthy hound-cross laboratory dogs, all intact 
females, were selected from an in-house colony. Dogs were relocated into a special 
laboratory dog ward and acclimated for 1 month prior to the start of the study.  
13C-glycocholic acid blood test (13C-GCBT). On day 0, following withholding 
of food overnight, indwelling jugular catheters were placed and baseline sera samples 
were collected. A 13C-GCBT was then carried out, using 1 mg/kg 13C-glycocholic acid 
(Glycocholic acid-13C [glycyl-1-13C], CDN Isotopes, Point-Claire, Quebec, Canada) 
mixed with an egg yolk and baked in a microwave for 1 minute. The baked egg yolk was 
then added to 5 g/kg bodyweight of a canned maintenance dog food (Hill’s Science Diet, 
Hill’s Science and Technology Center, Topeka, Kan.). Additional blood samples of 1 ml 
each were collected at 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 210, 240, 
270, 300, 330, 360, 390, 420, 450, and 480 min after 13C-glycocholic acid 
administration. Blood samples were immediately transferred into evacuated tubes 
(Vacutainer Sodium Lithium 10mL, Becton Dickinson, Franklin Lanes, New Jersey, 
USA) containing 2 ml of 6 N hydrochloric acid. After collection of the last blood 
samples jugular catheters were removed. The dogs then received 25 mg/kg tylosin 
(Tylan®) per os BID for 28 days. On day 28, jugular catheters were once again placed, 
baseline sera were collected, and the 13C-GCBT was repeated. Serum concentrations of 
cobalamin, folate, and unconjugated cholic acid were measured on days 0, 28, and 56 (4 
weeks after cessation of tylosin administration). Serum cobalamin and folate 
concentrations were measured using a commercially available automated competitive 
chemiluminescence immunoassay (DPC IMMULITE, Diagnostic Products Corp, 
Randolph, NJ.). SUCA concentrations were measured using solid-phase extraction 
followed by gas chromatography-mass spectrometry with selected ion monitoring as 
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described previously (76). The cumulative percent dose/min of 13C administered as GCA 
(CUMPCD) was determined in blood samples by fractional mass spectrometry 
(Automated Breath 13Carbon Analyzer, Europa Scientific Ltd, Crewe, UK). Data were 
analyzed using repeated measures ANOVA, or Friedman’s test if the data sets to be 
compared failed normality testing using Kolmogorov Smirnov normality test, followed 
by Bonferroni’s multiple comparison test. 
RESULTS 
Tylosin treatment was associated with significant changes of some of the marker 
tests for assessment of intestinal microflora in these dogs. Tables 7 to 9 and figures 15 to 
17 summarize the changes in serum concentrations of cobalamin, folate, and 
unconjugated cholic acid, respectively. While serum cobalamin concentrations did not 
differ significantly between the three measurements (Table 7 and Fig. 15), serum folate 
concentrations increased significantly after 4 weeks of tylosin administration from a 
mean±SD of 12.3±1.8 µg/L to 15.0±2.0 µg/L (p<0.001; Table 8 and Fig. 16). At day 56, 
four weeks after withdrawal of tylosin, the mean folate serum concentration was 
significantly higher compared to baseline (mean±SD: 14.6±2.4 µg/L; p<0.05) but not 
significantly different from day 28 (p>0.05). Similarly, SUCA concentration increased 
significantly after tylosin administration from a median serum concentration of 7.6 
nmol/L to 126.9 nmol/L (p<0.01; Table 9 and Fig. 17). After withdrawal of tylosin, 
median SUCA concentration was 23.3 nmol/L and was not significantly different from 
day 0 (p>0.05).  
The CUMPCD (determined up to 480 minutes) of the 13C-GCBT increased in 8 
out of 10 dogs after tylosin treatment (Figs. 18 and 19). Two-way ANOVA indicated 
that there was a significant effect of tylosin treatment (p<0.001) on the CUMPCD.  
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day 0 day 28 day 56
dog 1 413.0 428.0 445.0
dog 2 423.0 393.0 425.0
dog 3 393.0 447.0 401.0
dog 4 469.0 331.0 411.0
dog 5 401.0 426.0 420.0
dog 6 687.0 780.0 681.0
dog 7 351.0 441.0 544.0
dog 8 426.0 426.0 665.0
dog 9 794.0 927.0 876.0
dog 10 408.0 458.0 440.0
Mean 476.5 505.7 530.8
SD 144.4 189.9 159.9
Cobalamin (ng/L)
 
 
 
 
 
 
 
 
 
 
 
FIG 15. Serum concentrations of cobalamin (Vitamin B12) before (day 0), after 4 weeks 
of tylosin administration (day 28), and 4 weeks after withdrawal of tylosin (day 56). The 
bars depict the mean cobalamin concentration for each data set. 
 
 
 
TABLE 7. Serum concentrations of cobalamin (Vitamin B12) before (day 0), after 4 
weeks of tylosin administration (day 28), and 4 weeks after withdrawal of tylosin (day 
56). (SD = standard deviation) 
 
 
 
 
 
 
 
 
 80 
day 0 day 28 day 56
dog 1 11.5 14.3 12.8
dog 2 15.2 16.7 14.2
dog 3 11.0 19.7 13.3
dog 4 12.8 12.7 13.1
dog 5 9.9 14.0 16.1
dog 6 12.6 15.3 16.4
dog 7 12.9 17.8 13.7
dog 8 11.8 17.1 13.9
dog 9 13.4 15.4 17.8
dog 10 15.7 16.3 20.1
Mean 12.3 15.9 14.6
SD 1.8 2.0 2.4
Folate (µg/L)
 
 
 
 
 
 
 
 
 
 
 
 
FIG 16. Serum concentrations of folate before (day 0), after 4 weeks of tylosin 
administration (day 28), and 4 weeks after withdrawal of tylosin (day 56). The bars 
depict the mean serum folate concentrations for each data set. 
 
 
 
TABLE 8. Serum concentrations of folate before (day 0), after 4 weeks of tylosin 
administration (day 28), and 4 weeks after withdrawal of tylosin (day 56). (SD = 
standard deviation) 
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p<0.001 
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day 0 day 28 day 56
dog 1 4.2 118.0 31.4
dog 2 41.5 139.8 9.5
dog 3 1.9 35.9 22.8
dog 4 5.4 134.7 15.7
dog 5 52.3 242.6 325.4
dog 6 8.2 91.7 86.0
dog 7 4.1 73.0 3.1
dog 8 6.9 123.8 750.2
dog 9 40.3 129.9 9.5
dog 10 39.9 180.0 23.8
Median 7.6 126.9 23.3
SD 20.2 56.7 239.3
SUCA (nmol/L)
 
 
 
 
 
 
 
 
 
 
 
 
FIG 17. Serum concentrations of unconjugated cholic acid (SUCA) before (day 0), after 
4 weeks of tylosin administration (day 28), and 4 weeks after withdrawal of tylosin (day 
56). The bars depict the median SUCA concentrations for each data set. 
 
 
 
TABLE 9. Serum concentrations of unconjugated cholic acid (SUCA) before (day 0), 
after 4 weeks of tylosin administration (day 28), and 4 weeks after withdrawal of tylosin 
(day 56). (SD = standard deviation). 
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FIG 18. Cumulative percent dose/min of 13C administered as 13C-glycocholic acid 
(CUMPCD) before and after 4 weeks of tylosin administration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG 19. Changes in CUMPCD up to 480 minutes for the 13C-GCBT before (day 0) and 
after 4 weeks of tylosin administration (day 28) for each one of the 10 dogs enrolled.  
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DISCUSSION 
 Tylosin belongs to the macrolide class of antibiotics that is characterized by a 
multi-membered lactone ring (58). Antibiotics of the macrolide class inhibit bacterial 
protein synthesis by binding to the 50S ribosomal subunit (86). This inhibits the 
translocation of peptidyl-tRNA from the acceptor to the donor side on the ribosome as 
well as the initial steps of assembly of the 50S subunit (86). Tylosin has antibiotic 
activity predominantly against gram-positive bacteria (e.g., Stapylococcus spp., 
Streptococcus spp., and Clostridium spp.) and also against some Mycoplasma and 
Chlamydia spp. While tylosin also has an effect against some gram-negative bacteria 
(e.g., Campylobacter spp., Helicobacter pylori, Hemophilus spp., Pasteurella spp., and 
Legionella spp.) it has no effect against members of the Enterobacteriaceae group (e.g., 
Escherichia coli and Salmonella spp.). In pigs tylosin is an effective drug against the 
causative agent of proliferative enteropathy, Lawsonia intracellularis (86).  
 Some pathogenic bacteria including Clostridium perfringens and Campylobacter 
spp. have been suggested to play a role in the etiopathogenesis of chronic or intermittent 
diarrhea in dogs, and these bacteria are sensitive to tylosin (55). Tylosin also has been 
reported to have anti-inflammatory and immunomodulatory properties and may thus be 
useful in the treatment of canine chronic enteropathies such as inflammatory bowel 
disease (26, 86, 105).  
 Tylosin was chosen as an antibiotic agent for this study since it’s use is 
commonly recommended for the treatment of intestinal disorders such as small intestinal 
bacterial overgrowth or antibiotic-responsive diarrhea in dogs (105). Our hypothesis was 
that administration of tylosin leads to a reduction in small intestinal bacterial biomass 
reflected in changes of serum concentrations of indirect markers. More specifically we 
expected an increase in concentrations of serum cobalamin and a decrease in serum 
concentrations of folate and serum unconjugated cholic acid, and also a decrease of the 
cumulative percent dose/min of 13C administered as 13C-glycocholic acid (CUMPCD). In 
contrast to the hypothesis administration of tylosin was associated with an increase in 
serum concentrations of folate, serum unconjugated cholic acid (SUCA), and the 
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CUMPCD of the 13C-GCBT. Four weeks after withdrawal of tylosin (day 56), both mean 
serum folate concentrations and median SUCA decreased, albeit not significantly. Due 
to its complexity the 13C-glycocholic acid blood test was not repeated on day 56.   
In a previous study evaluating changes in indirect serum markers in dogs with tylosin-
responsive diarrhea the authors also reported that median SUCA concentrations 
increased after tylosin administration and decreased after withdrawal of tylosin. 
However, these changes in SUCA concentrations did not reach significance (105). 
Unlike in our study serum folate concentrations remained unchanged in that study (105). 
However, tylosin was administered for only 2 weeks and at a lower dose as each dog 
was given the minimum required dose  for controlling signs of diarrhea (the mean dose 
was 11 mg/kg q24 hours). This dose was much lower than the dose of tylosin used in our 
study (25 mk/kg q12 hours).  
 At this point it can only be speculated about reasons for the increase in 
concentrations of serum folate, SUCA, and CUMPCD of the 13C-GCBT. One 
explanation could be changes in the composition of the small intestinal microflora due to 
tylosin administration. For example, recent studies performed in pigs have shown that 
tylosin administration leads to changes in the composition of the ileal microflora in pigs 
(14). After 14 days of tylosin administration as a food additive, the total bacterial count 
decreased, but the percentage of Lactobacillus spp. increased significantly (14).  It has 
also been shown that some Lactobacillus spp. isolated from human feces (including L. 
johnsonii, L. acidophilus, L. brevis, L. casei, L. fermenti, L. plantarum, L. salivarius, L. 
aviarius, and Streptococcus alactolyticus) are capable of deconjugating glycocholic acid 
(27, 46, 60). Also, some lactic acid bacteria and Lactobacillus spp. (e.g., L. delbrueckii, 
L. plantarum, L. lactis, Streptococcus thermophilus) have been shown to synthesize 
folate (50, 99). Future studies need to directly evaluate qualitative and quantitative 
changes in the small intestinal microflora using bacterial culture techniques and 
molecular techniques to elucidate the effect of tylosin on the small intestinal microflora.  
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CHAPTER VII 
CONCLUSIONS 
 
The normal intestinal bacterial flora in dogs has not been well characterized. 
Previous studies have focused on enumeration and identification of bacterial species by 
direct culture of intestinal content. However, bacterial culture has limitations for 
assessment of bacterial diversity in intestinal samples as it is technically complex and 
expensive. Anaerobic bacteria, which are a substantial component of the intestinal 
microflora, are potentially more prone to damage during sampling, shipping, and storage 
and therefore may be underrepresented when assessing the microflora by bacterial 
culture. It is also now recognized that the majority of microbial species cannot be 
identified using standard culture techniques. Reasons for this inability to culture many 
bacterial species include non-viable or stressed microorganisms, obligate requirements 
for coexisting flora or host-derived products, bias due to selectivity of culture media, and 
a lack of knowledge regarding essential nutrients for some bacterial species. Thus, a 
culture-dependent approach may underestimate the bacterial diversity of complex 
microbial communities such as those found in the intestinal tract. This study was 
designed to characterize the composition and the dynamics of the canine intestinal 
microflora in healthy dogs using molecular methods and indirect serum markers.  
Molecular fingerprinting, based on amplification of the gene encoding the 16S 
ribosomal RNA (16S rDNA), has revealed marked differences in the qualitative 
composition of the intestinal microflora between individual dogs. Also, molecular 
fingerprinting has shown marked differences in the microflora between different areas of 
the intestine within individual dogs. Interestingly, the microflora in the ileum was highly 
variable. In one subset of dogs the ileal microflora showed higher similarity with the 
proximal small intestine, while in another subset of dogs it showed higher similarity with 
the large intestine. This is surprising as the ileocolic valve is believed to serve as a 
natural barrier between the small and large intestine in the dog. This barrier, together 
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with intestinal motility, is believed to prevent retrograde translocation of bacteria from 
the large into the small intestine. Dysfunction of the ileocolic valve has been suggested 
as a possible cause of intestinal disease, such as small intestinal bacterial overgrowth 
(SIBO). At this point it remains speculative that the variation in bacterial microflora in 
the ileum between different dogs is caused by dysfunction of the ileocolic valve, and if 
so, whether this has any clinical significance. Further studies evaluating changes in the 
ileal microflora in a large group of dogs with intestinal disease are warranted. These 
findings suggest that unknown, host-related factors, contribute to the development of a 
unique microflora in an individual, and that different compartments of the intestinal tract 
should be viewed as unique ecosystems. Differences in nutrient composition and 
concentration, differences in pH, and host secretions between various compartments of 
the intestine may contribute to this effect. Based on these findings, assessment of a fecal 
sample does not yield accurate information about the diversity of the microflora in 
proximal intestinal compartments. Therefore, for diagnosis of bacteria-associated small 
intestinal disease, samples need to be obtained from the small intestine rather than fecal 
samples. 
In this study two different collection techniques for obtaining small intestinal 
fluid for assessment of small intestinal bacterial diversity were evaluated: aspiration of 
duodenal juice through a sterile tube and the collection using a sterile disposable 
cytology brush. The aspiration technique proved to be impractical for routine clinical 
application since a considerable amount of time (approximately 10-20 min) was needed 
for each dog in order to collect a sufficient amount of duodenal juice. The collection of 
small intestinal fluid using a sterile cytology brush introduced through the working 
channel of the endoscope proved to be a rapid and reproducible collection technique and 
proper standardization should allow comparison of the bacterial diversity between 
healthy and diseased animals in future clinical studies.  
In contrast to the fecal microflora, which has been reported to be stable over 
time, molecular fingerprinting of samples collected from the duodenum at different time-
points varied within individuals, possibly due to variation of the bacterial flora over time 
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or a slight variation in sampling location. This variation of the small intestinal microflora 
obtained during repeated sampling, regardless of the underlying cause, needs to be taken 
into consideration when collecting samples from patients.  
Comparative 16S rDNA analysis revealed several previously uncharacterized 
16S rDNA sequences. Four major phylogenetic lineages were identified, with the 
majority of 16S rDNA sequences belonging to the order of Clostridiales, Bacteroidales, 
Lactobacillales, Enterobacteriales, and Fusobacteriales. These data indicate that the 
canine intestinal microflora is very complex, and that the molecular approach described 
in this study can facilitate identification of bacterial species in the canine intestinal tract 
that have not previously been characterized. Based on relative clone abundance a group 
of dogs had a predominant anaerobic microflora in the proximal small intestine (i.e., 
duodenum and jejunum), another group dogs had a predominantly aerobic microflora, 
whereas a third group of dogs had a mixed microflora. This observed marked inter-
individual variation in the qualitative composition of the intestinal microflora makes it 
difficult to establish parameters for a normal intestinal microflora. The clinical 
significance of the diverse intestinal microflora in dogs, and alterations in bacterial 
diversity that may occur with gastrointestinal disease, need to be further investigated. 
Studies that characterize the intestinal microflora in dogs with gastrointestinal disease are 
warranted, as potential undiscovered pathogens may be identified. Future studies also may 
aim to evaluate the diversity of the bacterial community within individuals. Reduction in 
community diversity may cause susceptibility to certain bacterial products and lead to 
intestinal disease. Molecular fingerprints could be used in future studies to evaluate 
community diversity. 
In contrast to our expectations, administration of tylosin, a commonly used 
antibiotic used in small animal gastroenterology, was associated with an increase in 
serum concentrations of folate, serum unconjugated cholic acid (SUCA), and the 
CUMPCD of the 13C-GCBT. These data suggest that tylosin administration is associated 
with alterations in the canine small intestinal flora, reflected in alterations in serum 
markers and dynamic tests of the small intestinal microflora. Increased serum folate, 
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SUCA, and CUMPCD in the C13-GCBT suggest that, in the dogs described here, tylosin 
administration increased the biomass of organisms carrying out these metabolic 
functions. Future studies are needed to directly assess qualitative and quantitative 
changes in the small intestinal microflora using bacterial culture and qualitative and 
quantitative molecular techniques to elucidate the effect of tylosin on the small intestinal 
microflora. It should also be recommended that tylosin administration should be 
discontinued before retesting serum concentrations of folate and SUCA and 13GCABT. 
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